DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women		11q14.1	11	78008566.0	intergenic	INTS4 - KCTD14	ENSG00000149262	ENSG00000151364		13895.0	7149.0	rs10899426-?	rs10899426	0	10899426.0	intergenic_variant	1	NR	2e-07	6.698970004336019		2.74		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women		11p15.3	11	13492506.0	PTH	PTH			ENSG00000152266			rs6256-?	rs6256	0	6256.0	stop_gained	0	NR	1e-06	6.0		1.93		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women		11p15.3	11	13553087.0	intergenic	PTH - HMGN2P36	ENSG00000152266	ENSG00000228901		56906.0	57276.0	rs10832063-?	rs10832063	0	10832063.0	intergenic_variant	1	NR	5e-06	5.301029995663981		1.8		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women		11p15.3	11	13401400.0	BTBD10	BTBD10			ENSG00000148925			rs10500780-?	rs10500780	0	10500780.0	intron_variant	0	NR	5e-06	5.301029995663981		1.79		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		10p12.1	10	26722183.0	PDSS1	PDSS1			ENSG00000148459			rs1564271-?	rs1564271	0	1564271.0	intron_variant	0	NR	9e-06	5.045757490560675		1.62		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		11q14.1	11	78008566.0	intergenic	INTS4 - KCTD14	ENSG00000149262	ENSG00000151364		13895.0	7149.0	rs10899426-?	rs10899426	0	10899426.0	intergenic_variant	1	NR	9e-06	5.045757490560675		2.29		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		6p25.3	6	1492427.0	intergenic	FOXF2 - RN7SL352P	ENSG00000137273	ENSG00000243439		96824.0	14895.0	rs4618572-?	rs4618572	0	4618572.0	intergenic_variant	1	NR	9e-06	5.045757490560675		1.86		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		3q23	3	141643383.0	intergenic	RASA2 - LINC02618	ENSG00000155903	ENSG00000242104		28039.0	17153.0	rs295315-?	rs295315	0	295315.0	intergenic_variant	1	NR	8e-07	6.096910013008056		1.82		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		10q23.1	10	80608465.0	SH2D4B	SH2D4B			ENSG00000178217			rs17693104-?	rs17693104	0	17693104.0	intron_variant	0	NR	8e-07	6.096910013008056		1.65		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		3q23	3	141658488.0	LOC646730	RASA2 - LINC02618	ENSG00000155903	ENSG00000242104		43144.0	2048.0	rs868767-?	rs868767	0	868767.0	upstream_gene_variant	1	NR	2e-06	5.698970004336019		2.12		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		20p11.21	20	24451198.0	intergenic	GAPDHP53 - SYNDIG1	ENSG00000234069	ENSG00000101463		4884.0	18431.0	rs2050203-?	rs2050203	0	2050203.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		1.78		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		14q32.31	14	101629499.0	intergenic	DIO3 - LINC02320	ENSG00000197406	ENSG00000258404		66047.0	4955.0	rs11621975-?	rs11621975	0	11621975.0	intron_variant	1	NR	5e-06	5.301029995663981		2.31		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		12q23.2	12	102981636.0	intergenic	ASCL1 - NA	ENSG00000139352			21123.0		rs17548007-?	rs17548007	0	17548007.0	intergenic_variant	1	NR	5e-06	5.301029995663981		1.86		Illumina [636555]	N
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women		8q21.13	8	81290982.0	intergenic	FABP5 - NA	ENSG00000164687			6205.0		rs202280-?	rs202280	0	202280.0	intergenic_variant	1	NR	6e-06	5.221848749616356		2.0		Illumina [636555]	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls		3q25.31	3	156717851.0	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923.0	29492.0	rs62274041-G	rs62274041	0	62274041.0	intergenic_variant	1	0.0481682	5e-07	6.301029995663981		1.4226197	[1.23974783491848-1.63246639995579]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls		4q32.3	4	164987569.0	NR	TRIM61 - TRIM60	ENSG00000183439	ENSG00000176979		9901.0	28889.0	rs4691139-G	rs4691139	0	4691139.0	non_coding_transcript_exon_variant	1	0.467	4e-07	6.3979400086720375		1.1581223	[1.09413051760919-1.22585676557555]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls		9p22.2	9	16915876.0	NR	BNC2 - NA	ENSG00000173068			45033.0		rs10962692-G	rs10962692	0	10962692.0	intergenic_variant	1	0.799624	1e-14	14.0		1.3346913	[1.24035297950519-1.43620468676761]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA1 mutation carriers	2,933 European ancestry carrier cases, 16,103 European ancestry carrier controls		17q21.31	17	45489971.0	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586.0	intron_variant	0	0.181254	7e-06	5.154901959985743		1.1804551	[1.0983093028467-1.26874471717965]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319015999999999	4e-14	13.397940008672036		1.1120843	[1.08193543636327-1.14307327686388]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319447	4e-14	13.397940008672036		1.1121821	[1.0819829343715-1.14322428681774]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		3q25.31	3	156717851.0	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923.0	29492.0	rs62274041-G	rs62274041	0	62274041.0	intergenic_variant	1	0.0481682	5e-38	37.30102999566398		1.4494933	[1.3698151996842-1.53380589540381]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		4q26	4	119028805.0	NR	SYNPO2			ENSG00000172403			rs17329882-C	rs17329882	0	17329882.0	intron_variant	0	0.241	3e-06	5.522878745280337		1.07509	[1.0431816063-1.1079744406]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		5p15.33	5	1279675.0	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690.0	intron_variant	0	0.259806	3e-08	7.522878745280337		1.0865872	[1.05501477967445-1.11910451351639]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		5p15.33	5	1285859.0	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526.0	intron_variant	0	0.332078	7e-10	9.154901959985745		1.0913801	[1.06151189081851-1.12208885346329]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls					NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	2e-08	7.698970004336019		1.1555611	[1.09892839652449-1.21511227508431]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		8q24.21	8	128529685.0	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482.0	intron_variant	0	0.867974	7e-16	15.154901959985745		1.1769707	[1.13116083835271-1.22463593511406]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		9p22.2	9	16915876.0	NR	BNC2 - NA	ENSG00000173068			45033.0		rs10962692-G	rs10962692	0	10962692.0	intergenic_variant	1	0.799624	8.999999999999999e-36	35.045757490560675		1.2424945	[1.20065901834152-1.28578755258347]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls					NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	8e-10	9.096910013008056		1.1083262	[1.07253217567565-1.14531490798434]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		10p12.31	10	21589903.0	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911.0	intron_variant	0	0.309302	8e-10	9.096910013008056		1.0908245	[1.06101278339562-1.12147377629663]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		15q26.1	15	90963407.0	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282.0	2633.0	rs8037137-C	rs8037137	0	8037137.0	intergenic_variant	1	0.134	5e-07	6.301029995663981		1.098901	[1.06-1.15]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		17q11.2	17	30854203.0	NR	ATAD5			ENSG00000176208			rs143663961-A	rs143663961	0	143663961.0	intron_variant	0	0.72942	1e-07	7.0		1.0819896	[1.05072828447598-1.11418107368593]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		17q21.31	17	45489971.0	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586.0	intron_variant	0	0.181254	2e-13	12.69897000433602		1.1339011	[1.09660984313914-1.1724605092959]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		17q21.32	17	48423311.0	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826.0	intron_variant	0	0.267801	8e-13	12.096910013008056		1.1105318	[1.07914609971847-1.14283031731538]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		19p13.11	19	17279482.0	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075.0	intron_variant	0	0.295975	2e-17	16.69897000433602		1.1302502	[1.09887004937136-1.1625264094177]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		22q12.1	22	28538325.0	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807.0	intron_variant	0	0.898635	3e-07	6.522878745280337		1.1211612	[1.07314763387262-1.17132308995474]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		2q13	2	111061081.0	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109.0	intron_variant	0	0.251869	8e-07	6.096910013008056		1.0780069	[1.04637703624974-1.11059270801828]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Invasive epithelial ovarian cancer	22,406 European ancestry cases, 40,941 European ancestry controls		12q24.31	12	120965921.0	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249.0	splice_region_variant	0	0.417632	6e-06	5.221848749616356		1.0621586	[1.0348111352015-1.09022867520121]	Illumina [11595112] (imputed)	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1q23.3	1	161352208.0	SDHC	SDHC			ENSG00000143252			rs12140361-?	rs12140361	0	12140361.0	intron_variant	0	NR	3e-06	5.522878745280337	(adjusted for dose, GFR & AST)	7.098	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1q22	1	156193927.0	SLC25A44	SEMA4A - SLC25A44	ENSG00000196189	ENSG00000160785		16175.0	5.0	rs2241111-?	rs2241111	0	2241111.0	TF_binding_site_variant	1	NR	6e-06	5.221848749616356		4.844	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		15q25.2	15	81554938.0	TMC3, MEX3B	TMC3-AS1 - NA	ENSG00000259343			36738.0		rs969348-?	rs969348	0	969348.0	intron_variant	1	NR	6e-06	5.221848749616356		5.866	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		2q14.3	2	122620366.0	TSN, CNTNAP5							rs7566539-?	rs7566539	0	7566539.0	intron_variant	1	NR	3e-06	5.522878745280337	(adjusted for dose, GFR & AST)	7.171	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		16q23.2	16	79311795.0	WWOX, MAF	RNA5SP431 - NA	ENSG00000222244			47222.0		rs9934640-?	rs9934640	0	9934640.0	regulatory_region_variant	1	NR	5e-06	5.301029995663981	(adjusted for dose, GFR & AST)	8.074	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		3q26.1	3	166315136.0	ZBBX, BCHE							rs9283636-?	rs9283636	0	9283636.0	intergenic_variant	1	NR	5e-07	6.301029995663981	(adjusted for dose, GFR & AST)	3.049	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		2q35	2	217010416.0	DIRC3, TNP1							rs12165173-?	rs12165173	0	12165173.0	TF_binding_site_variant	1	NR	5e-06	5.301029995663981	(adjusted for dose, GFR & AST)	1.06	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		10q22.1	10	69910197.0	COL13A1	COL13A1			ENSG00000197467			rs12412836-?	rs12412836	0	12412836.0	intron_variant	0	NR	4e-06	5.3979400086720375	(adjusted for dose, GFR & AST)	0.75	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		10q23.1	10	85041429.0	FAM190B, LOC100507470							rs12571637-?	rs12571637	0	12571637.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(adjusted for dose, GFR & AST)	1.59	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		14q32.2	14	96778118.0	PAPOLA, VRK1	LINC02299			ENSG00000258979			rs17280534-?	rs17280534	0	17280534.0	intron_variant	0	NR	6e-06	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		7q36.1	7	151487834.0	RHEB	RHEB			ENSG00000106615			rs17635967-?	rs17635967	0	17635967.0	intron_variant	0	NR	6e-06	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		6q21	6	105789630.0	PREP, PRDM1							rs2202766-?	rs2202766	0	2202766.0	intron_variant	1	NR	7e-06	5.154901959985743	(adjusted for dose, GFR & AST)	1.47	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		15q14	15	38490292.0	RASGRP1	RASGRP1			ENSG00000172575			rs4313770-?	rs4313770	0	4313770.0	3_prime_UTR_variant	0	NR	6e-06	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		4p15.2	4	27184810.0	STIM2, MIR4275	NA - LINC02261		ENSG00000249699			32669.0	rs4692174-?	rs4692174	0	4692174.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(adjusted for dose, GFR & AST)	0.88	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		20q11.23	20	38323940.0	BPI	BPI			ENSG00000101425			rs5741804-?	rs5741804	0	5741804.0	missense_variant	0	NR	9e-06	5.045757490560675	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		11q12.2	11	61792563.0	C11orf10	TMEM258			ENSG00000134825			rs7102974-?	rs7102974	0	7102974.0	5_prime_UTR_variant	0	NR	6e-06	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		18q11.2	18	27347470.0	RP11-739N10	NA - UBA52P9		ENSG00000244329			7936.0	rs7230264-?	rs7230264	0	7230264.0	intron_variant	1	NR	9e-07	6.045757490560675	(adjusted for dose, GFR & AST)	0.65	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		10p12.1	10	25602315.0	GPR158	GPR158 - GPN3P1	ENSG00000151025	ENSG00000227465		86.0	45255.0	rs7909167-?	rs7909167	0	7909167.0	intergenic_variant	1	NR	6e-06	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		10q24.2	10	99850776.0	ABCC2	ABCC2			ENSG00000023839			rs8187707-?	rs8187707	0	8187707.0	synonymous_variant	0	NR	5e-06	5.301029995663981	(adjusted for dose, GFR & AST)	1.21	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		21q21.3	21	25631797.0	MRPL39, JAM2	MRPL39 - JAM2	ENSG00000154719	ENSG00000154721		24280.0	7461.0	rs9982086-?	rs9982086	0	9982086.0	intergenic_variant	1	NR	9e-06	5.045757490560675	(adjusted for dose, GFR & AST)	1.06	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		13q33.3	13	107290084.0	FAM155A	FAM155A						rs9558996-?	rs9558996	0	9558996.0	intron_variant	0	NR	5e-06	5.301029995663981		1.285	unit increase (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		3p14.3	3	55376983.0	CACNA2D3, WNT5A	LINC02030 - WNT5A	ENSG00000240708	ENSG00000114251		76245.0	88732.0	rs11130471-?	rs11130471	0	11130471.0	intergenic_variant	1	NR	9e-06	5.045757490560675		1.641	unit decrease (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		4q31.21	4	145811502.0	ZNF827	ZNF827			ENSG00000151612			rs17806780-?	rs17806780	0	17806780.0	intron_variant	0	NR	9e-06	5.045757490560675		1.484	unit increase (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases		5q31.2	5	138109311.0	WNT8A, NME5	WNT8A - NME5	ENSG00000061492	ENSG00000112981		16946.0	5864.0	rs12516561-?	rs12516561	0	12516561.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		1.671	unit increase (EA)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		17q24.3	17	69228706.0	ABCA10	ABCA10			ENSG00000154263			rs9302891-?	rs9302891	0	9302891.0	5_prime_UTR_variant	0	NR	7e-06	5.154901959985743	(adjusted for dose, GFR & AST)	6.616	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		10q25.3	10	114642349.0	ABLIM1	ABLIM1			ENSG00000099204			rs2483519-?	rs2483519	0	2483519.0	intron_variant	0	NR	2e-06	5.698970004336019	(adjusted for dose, GFR & AST)	2.729	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		13q33.3	13	107030239.0	ARGLU1, FAM155A	LINC00393 - NA	ENSG00000224853			33368348.0		rs16969611-?	rs16969611	0	16969611.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(adjusted for dose, GFR & AST)	3.629	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		3q26.1	3	166329716.0	BCHE, ZBBX							rs1574560-?	rs1574560	0	1574560.0	intergenic_variant	1	NR	6e-07	6.221848749616356	(adjusted for dose, GFR & AST)	3.049	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		14q24.3	14	76937083.0	C14orf166B, IRF2BPL	RN7SKP17 - LINC01629	ENSG00000223174	ENSG00000258602		46470.0	22555.0	rs2056859-?	rs2056859	0	2056859.0	regulatory_region_variant	1	NR	2e-06	5.698970004336019		11.03	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		10q22.2	10	73894042.0	CAMK2G, C10orf55	CAMK2G - PLAU	ENSG00000148660	ENSG00000122861		19451.0	15135.0	rs17741873-?	rs17741873	0	17741873.0	intergenic_variant	1	NR	8e-06	5.096910013008056	(adjusted for dose, GFR & AST)	2.888	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		2p16.1	2	57804114.0	CCDC85A, VRK2	ACTG1P22 - NA	ENSG00000271615			38062.0		rs1851138-?	rs1851138	0	1851138.0	intergenic_variant	1	NR	6e-06	5.221848749616356		6.833	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1p36.12	1	20620263.0	CDA, PINK1	CDA - PINK1	ENSG00000158825	ENSG00000158828		1360.0	13195.0	rs1614627-?	rs1614627	0	1614627.0	intergenic_variant	1	NR	6e-07	6.221848749616356		7.424	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		10p14	10	8603200.0	GATA3	KRT8P37 - CHCHD3P1	ENSG00000213771	ENSG00000236420		88094.0	16733.0	rs9787692-?	rs9787692	0	9787692.0	intergenic_variant	1	NR	7e-07	6.154901959985743	(adjusted for dose, GFR & AST)	3.672	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		4q34.1	4	174644094.0	GLRA3	GLRA3			ENSG00000145451			rs4235212-?	rs4235212	0	4235212.0	intron_variant	0	NR	6e-06	5.221848749616356		2.503	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		3p26.1	3	7956266.0	GRM7, LOC100288428	LMCD1-AS1			ENSG00000227110			rs10510382-?	rs10510382	0	10510382.0	intron_variant	0	NR	6e-06	5.221848749616356		3.033	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		16p12.1	16	25955783.0	HS3ST4	HS3ST4			ENSG00000182601			rs9938946-?	rs9938946	0	9938946.0	intron_variant	0	NR	3e-06	5.522878745280337		3.774	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		18q11.2	18	26521596.0	KCTD1	KCTD1			ENSG00000134504			rs8083427-?	rs8083427	0	8083427.0	intron_variant	0	NR	3e-06	5.522878745280337		5.467	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		10p11.23	10	30080931.0	KIAA1462, MTPAP	JCAD			ENSG00000165757			rs2505127-?	rs2505127	0	2505127.0	intron_variant	0	NR	6e-06	5.221848749616356	(adjusted for dose, GFR & AST)	5.005	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1p22.3	1	87773925.0	LOC100505768, PKN2	PKN2-AS1			ENSG00000237505			rs17130142-?	rs17130142	0	17130142.0	intron_variant	0	NR	2e-07	6.698970004336019		8.641	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1p31.1	1	81208812.0	LPHN2	NA - RN7SKP247		ENSG00000223026			42977.0	rs17131753-?	rs17131753	0	17131753.0	non_coding_transcript_exon_variant	1	NR	7e-06	5.154901959985743		7.784	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		18q23	18	77003313.0	MBP	MBP			ENSG00000197971			rs470903-?	rs470903	0	470903.0	non_coding_transcript_exon_variant	0	NR	3e-06	5.522878745280337	(adjusted for dose, GFR & AST)	5.453	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		13q34	13	109657033.0	MYO16, IRS2	NA - LINC00676		ENSG00000234854			71249.0	rs11840576-?	rs11840576	0	11840576.0	intron_variant	1	NR	2e-06	5.698970004336019		8.684	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		12p13.33	12	674318.0	NINJ2, WNK1	NINJ2-AS1 - LINC02455	ENSG00000177406	ENSG00000256672		10122.0	483.0	rs12425791-?	rs12425791	0	12425791.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		2.026	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		14q31.1	14	79888998.0	NRXN3, DIO2	NRXN3 - NA	ENSG00000021645			20707.0		rs2205226-?	rs2205226	0	2205226.0	intergenic_variant	1	NR	5e-06	5.301029995663981		4.956	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		8q23.1	8	106314611.0	OXR1	OXR1			ENSG00000164830			rs7013285-?	rs7013285	0	7013285.0	intron_variant	0	NR	3e-06	5.522878745280337	(adjusted for dose, GFR & AST)	3.067	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1q22	1	156219495.0	PMF1, PMF1-BGLAP	PMF1, PMF1-BGLAP			ENSG00000160783, ENSG00000260238			rs2758596-?	rs2758596	0	2758596.0	intron_variant	0	NR	6e-06	5.221848749616356		4.844	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		7q33	7	137259485.0	PTN	PTN			ENSG00000105894			rs17169015-?	rs17169015	0	17169015.0	intron_variant	0	NR	5e-06	5.301029995663981		18.28	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		1p35.3	1	29429306.0	PTPRU, MATN1	LINC01756 - NA	ENSG00000230523			79192.0		rs16838233-?	rs16838233	0	16838233.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		5.346	unit increase (EA, Australian cohort)	Illumina [610255]	N
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Paclitaxel disposition in epithelial ovarian cancer	66 European ancestry cases, 14 Asian ancestry cases		14q11.2	14	20698124.0	RNASE4	RNASE4, EGILA, ANG			ENSG00000258818, ENSG00000258451, ENSG00000214274			rs17211649-?	rs17211649	0	17211649.0	intron_variant	0	NR	2e-06	5.698970004336019		14.22	unit increase (EA, Dutch cohort)	Illumina [610255]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		1p36.13	1	16013277.0	HSPB7	SRARP - HSPB7	ENSG00000183888	ENSG00000173641		4470.0	751.0	rs1763604-C	rs1763604	0	1763604.0	downstream_gene_variant	1	0.42085	7e-09	8.154901959985743		0.0372	[0.025-0.05] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		1q21.3	1	155016057.0	ZBTB7B	ZBTB7B			ENSG00000160685			rs77548871-C	rs77548871	0	77548871.0	intron_variant	0	0.0472	5e-09	8.301029995663981		0.0991	[0.066-0.132] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		2p11.2	2	85573959.0	NR	VAMP8			ENSG00000118640			rs13007211-A	rs13007211	0	13007211.0	intron_variant	0	0.6935	1e-09	9.0		0.0432	[0.029-0.057] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		2q13	2	111138666.0	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs17041869-A	rs17041869	0	17041869.0	intron_variant	0	0.8804	2e-09	8.698970004336019		0.0571	[0.038-0.076] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		4q24	4	105137029.0	TET2	NA - TET2		ENSG00000168769			8846.0	rs57251748-CT	rs57251748	0	57251748.0	regulatory_region_variant	1	0.15	9e-12	11.045757490560677		0.0598	[0.043-0.077] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		7p15.1	7	27950149.0	JAZF1	JAZF1			ENSG00000153814			rs739704-A	rs739704	0	739704.0	intron_variant	0	0.2515	3e-14	13.522878745280336		0.0542	[0.04-0.068] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		7q35	7	144377836.0	ARHGEF5	ARHGEF5, ARHGEF5			ENSG00000050327, ENSG00000284933			rs720475-A	rs720475	0	720475.0	intron_variant	0	0.25455	7e-12	11.154901959985745		0.0495	[0.035-0.064] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		8q24.21	8	126990792.0	PCAT1/PCAT2	PCAT1			ENSG00000253438			rs17762342-A	rs17762342	0	17762342.0	intron_variant	0	0.7935	2e-15	14.69897000433602		0.061	[0.046-0.076] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		8q24.21	8	128187668.0	MIR1208/PVT1	PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		567.0	32836.0	rs3802173-T	rs3802173	0	3802173.0	intergenic_variant	1	0.2261	3e-11	10.522878745280336		0.0521	[0.037-0.068] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		9p21.3	9	21956231.0	CDKN2A/CDKN2B	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		18580.0	10698.0	rs9657608-T	rs9657608	0	9657608.0	intron_variant	1	0.0923	1e-10	10.0		0.0685	[0.048-0.089] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		10p12.31	10	22010574.0	DNAJC1	DNAJC1 - NA	ENSG00000136770			6805.0		rs7898685-A	rs7898685	0	7898685.0	regulatory_region_variant	1	0.2913	3e-10	9.522878745280336		0.0428	[0.029-0.056] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		10q25.3	10	113390512.0	HABP2	RNU7-165P - PPIAP39	ENSG00000238380	ENSG00000230018		37028.0	92104.0	rs568110-T	rs568110	0	568110.0	regulatory_region_variant	1	0.2057	5e-12	11.30102999566398		0.0523	[0.037-0.067] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		11q12.3	11	62126500.0	INCENP	INCENP			ENSG00000149503			rs7937840-T	rs7937840	0	7937840.0	intron_variant	0	0.26465	2e-09	8.698970004336019		0.0446	[0.03-0.059] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		11q13.2	11	66324772.0	NR	CD248 - RIN1	ENSG00000174807	ENSG00000174791		7728.0	5469.0	rs118151305-A	rs118151305	0	118151305.0	intergenic_variant	1	0.12004999999999999	6e-09	8.221848749616356		0.0672	[0.045-0.09] unit decrease	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		11q13.3	11	69138652.0	TPCN2	TPCN2 - SMIM38	ENSG00000162341	ENSG00000284713		2336.0	16826.0	rs72932523-A	rs72932523	0	72932523.0	intron_variant	1	0.10565	1e-09	9.0		0.0601	[0.041-0.08] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		14q32.11	14	91283251.0	CCDC88C	CCDC88C			ENSG00000015133			rs2277509-A	rs2277509	0	2277509.0	intron_variant	0	0.69865	9e-12	11.045757490560677		0.0466	[0.033-0.06] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		17q22	17	55135212.0	STXBP4	STXBP4			ENSG00000166263			rs2628317-A	rs2628317	0	2628317.0	intron_variant	0	0.72985	4e-16	15.397940008672036		0.0582	[0.044-0.072] unit increase	Illumina [NR]	N
2020-12-01	27432226	Kar SP	2016-07-17	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/27432226	Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.	Breast cancer, ovarian cancer or prostate cancer (pleiotropy)	62,533 European ancestry breast cancer female cases, 60,976 European ancestry controls, 15,437 European ancestry invasive epithelial ovarian cancer female cases, 30,845 European ancestry controls, 34,379 European ancestry prostate cancer male cases, 33,164 European ancestry controls		19p13.11	19	19417997.0	GATAD2A	GATAD2A			ENSG00000167491			rs1469713-A	rs1469713	0	1469713.0	intron_variant	0	0.64405	1e-10	10.0		0.043	[0.03-0.056] unit decrease	Illumina [NR]	N
2014-02-10	21964575	Rafnar T	2011-10-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21964575	Mutations in BRIP1 confer high risk of ovarian cancer.	Ovarian cancer	640 European ancestry cases, 41,607 European ancestry controls		17q23.2	17	61803285.0	BRIP1	BRIP1			ENSG00000136492			rs34289250-C	rs34289250	0	34289250.0	intron_variant	0	0.0089	6e-13	12.221848749616356		7.95	[NR]	Illumina [15957390] (imputed)	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	10p11.21	10	36880367.0	NAMPTL, ANKRD30A	NA - MKNK2P1		ENSG00000233533			63744.0	rs1192691-C	rs1192691	0	1192691.0	intergenic_variant	1	0.54	3e-08	7.522878745280337		1.23	[1.05-1.43]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	12q14.2	12	63871057.0	SRGAP1	SRGAP1			ENSG00000196935			rs11175194-G	rs11175194	0	11175194.0	intron_variant	0	0.59	1e-07	7.0		1.19	[1.02-1.39]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	9q34.2	9	133279871.0	SURF6, ABO	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3847.0	22599.0	rs633862-A	rs633862	0	633862.0	upstream_gene_variant	1	0.54	9e-07	6.045757490560675		1.19	[1.02-1.39]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	9q22.33	9	98998959.0	TGFBR1, COL15A1	COL15A1			ENSG00000204291			rs1413299-C	rs1413299	0	1413299.0	intron_variant	0	0.38	2e-08	7.698970004336019		1.2	[1.03-1.41]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	1q44	1	244077146.0	ZNF238, ADSS	ZBTB18 - RN7SL148P	ENSG00000179456	ENSG00000244066		19670.0	26786.0	rs2500488-C	rs2500488	0	2500488.0	intron_variant	1	0.33	4e-06	5.3979400086720375		1.472	[1.246-1.739]	Illumina [710714]	N
2015-04-16	25134534	Chen K	2014-08-19	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25134534	Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.	Epithelial ovarian cancer	1,044 Han Chinese ancestry cases, 1,172 Han Chinese ancestry controls	1,452 Han Chinese ancestry cases, 2,803 Han Chinese ancestry controls	7q21.11	7	83667946.0	SEMA3E, ABCB4	RAD23BP2 - NA	ENSG00000230244			3321.0		rs6976769-C	rs6976769	0	6976769.0	intergenic_variant	1	.05	4e-06	5.3979400086720375		1.458	[1.056-2.012]	Illumina [710714]	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls		3p26.1	3	7963141.0	LOC101927394	LMCD1-AS1			ENSG00000227110			rs7643459-T	rs7643459	0	7643459.0	intron_variant	0	0.362	8e-07	6.096910013008056		1.4	[1.22-1.60]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls		4q13.3	4	69576447.0	UGT2A2	UGT2B4 - UGT2A1	ENSG00000156096	ENSG00000173610		50433.0	11970.0	rs4286604-G	rs4286604	0	4286604.0	intron_variant	1	0.732	9e-07	6.045757490560675		1.4492754	[1.25-1.69]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls		5q34	5	168286995.0	WWC1	CTB-178M22.2 - WWC1	ENSG00000253978	ENSG00000113645		17580.0	4650.0	rs142091544-T	rs142091544	0	142091544.0	regulatory_region_variant	1	0.034	9e-07	6.045757490560675		3.22	[2.02-5.13]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	Epithelial ovarian cancer	755 African ancestry cases, 1,235 African ancestry controls		10p15.1	10	5049762.0	AKR1C3	AKR1C3			ENSG00000196139			rs4525119-C	rs4525119	0	4525119.0	intron_variant	0	0.669	5e-07	6.301029995663981		1.4285715	[1.23-1.64]	Illumina [12486624] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls		5q11.2	5	53348817.0	FST							rs37792-A	rs37792	0	37792.0	intergenic_variant	1	0.658	6e-08	7.221848749616356		1.5384616	[1.32-1.82]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls		Xq27.2	X	141990766.0	MAGEC1	MAGEC1 - NA	ENSG00000155495			81392.0		rs57403204-G	rs57403204	0	57403204.0	intron_variant	1	0.064	2e-07	6.698970004336019		2.62	[1.83-3.76]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls		10p15.2	10	3641956.0	LOC105376360							rs79079890-G	rs79079890	0	79079890.0	intergenic_variant	1	0.032	3e-07	6.522878745280337		3.2	[2.05-4.99]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls		17q25.1	17	76359184.0	PRPSAP1	PRPSAP1			ENSG00000161542			rs66459581-A	rs66459581	0	66459581.0	intron_variant	0	0.234	5e-07	6.301029995663981		1.63	[1.35-1.97]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls		15q12	15	26986803.0	GABRG3	GABRG3			ENSG00000182256			rs116046250-G	rs116046250	0	116046250.0	intron_variant	0	0.046	9e-07	6.045757490560675		2.95	[1.92-4.54]	Illumina [11083029] (imputed)	N
2019-11-08	31469419	Manichaikul A	2019-08-30	Int J Cancer	www.ncbi.nlm.nih.gov/pubmed/31469419	Identification of novel epithelial ovarian cancer loci in Women of African Ancestry.	High-grade serous ovarian cancer	537 African ancestry cases, 1,235 African ancestry controls		4q21.21	4	79376097.0	LOC105377300, GK2	NAA11 - GK2	ENSG00000156269	ENSG00000196475		50036.0	30264.0	rs192876988-C	rs192876988	0	192876988.0	intergenic_variant	1	0.046	9e-07	6.045757490560675		3.01	[1.94-4.68]	Illumina [11083029] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1p36.33	1	1351675.0	Intergenic	DVL1 - MXRA8	ENSG00000107404	ENSG00000162576		2257.0	1014.0	rs186507655-A	rs186507655	0	186507655.0	regulatory_region_variant	1	NR	5e-10	9.30102999566398	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q22	1	155212373.0	MTX1	MTX1			ENSG00000173171			rs2075570-T	rs2075570	0	2075570.0	intron_variant	0	NR	5e-06	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		3p24.1	3	27285723.0	NEK10	NEK10			ENSG00000163491			rs481519-T	rs481519	0	481519.0	intron_variant	0	NR	2e-09	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		4q24	4	105140377.0	Intergenic	RNU6-351P - TET2	ENSG00000251906	ENSG00000168769		165606.0	5498.0	rs7679673-A	rs7679673	0	7679673.0	intron_variant	1	NR	1e-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		5p15.33	5	1282299.0	TERT	TERT			ENSG00000164362			rs7725218-A	rs7725218	0	7725218.0	intron_variant	0	NR	2e-10	9.69897000433602	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		5q11.2	5	56737113.0	Intergenic	NA - MAP3K1		ENSG00000095015			78436.0	rs1862626-T	rs1862626	0	1862626.0	intergenic_variant	1	NR	4e-12	11.397940008672036	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p22.1	6	29785031.0	Intergenic	IFITM4P - HLA-V	ENSG00000233023	ENSG00000223606		33883.0	5923.0	rs147680653-G	rs147680653	1	9258375.0	intergenic_variant	1	NR	1e-06	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p22.1	6	30374976.0	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696.0	39739.0	rs115707823-A	rs115707823	1	3129817.0	intergenic_variant	1	NR	5e-07	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.33	6	31347004.0	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		45362.0	6868.0	rs115392158-G	rs115392158	1	2507997.0	intron_variant	1	NR	3e-07	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.32	6	32699696.0	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313.0	6428.0	rs147527678-C	rs147527678	1	1794514.0	intergenic_variant	1	NR	6e-08	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		9p21.3	9	22062135.0	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970.0	intron_variant	0	NR	5e-06	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		10q26.13	10	121575416.0	FGFR2	FGFR2			ENSG00000066468			rs11200014-A	rs11200014	0	11200014.0	intron_variant	0	NR	8e-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		11q13.3	11	69227030.0	Intergenic	SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		67278.0	67121.0	rs7931342-G	rs7931342	0	7931342.0	intergenic_variant	1	NR	4e-14	13.397940008672036	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		11q22.3	11	103813371.0	Intergenic	NA - MIR4693		ENSG00000264200			36535.0	rs148883465-G	rs148883465	0	148883465.0	intron_variant	1	NR	3e-08	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q13.12	12	49251457.0	TUBA1C	TUBA1C			ENSG00000167553			rs11168936-C	rs11168936	0	11168936.0	intron_variant	0	NR	9e-07	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q13.13	12	52918828.0	KRT8	KRT8			ENSG00000170421			rs73110464-T	rs73110464	0	73110464.0	intron_variant	0	NR	2e-15	14.69897000433602	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q24.12	12	111446804.0	SH2B3	ATXN2, SH2B3			ENSG00000204842, ENSG00000111252			rs3184504-C	rs3184504	0	3184504.0	missense_variant	0	NR	1e-06	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32394673.0	BRCA2	BRCA2			ENSG00000139618			rs11571818-C	rs11571818	0	11571818.0	intron_variant	0	NR	5e-10	9.30102999566398	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		14q24.1	14	68559662.0	RAD51B	RAD51B			ENSG00000182185			rs11844632-A	rs11844632	0	11844632.0	intron_variant	0	NR	3e-10	9.522878745280336	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		17q12	17	37741642.0	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991.0	intron_variant	0	NR	7e-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		19p13.11	19	17279482.0	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075.0	intron_variant	0	NR	2e-09	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34131991.0	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701.0	62578.0	rs11907546-T	rs11907546	0	11907546.0	intergenic_variant	1	NR	3e-06	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		11q22.3	11	103745837.0	Intergenic							rs141752671-G	rs141752671	0	141752671.0	intron_variant	1	NR	1e-07	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q24.12	12	111621753.0	Intergenic	ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497.0	20393.0	rs11065979-T	rs11065979	0	11065979.0	intergenic_variant	1	NR	5e-06	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34002002.0	RALY	RALY			ENSG00000125970			rs2300206-C	rs2300206	0	2300206.0	intron_variant	0	NR	6e-06	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32295727.0	FRY	FRY			ENSG00000073910			rs56084662-A	rs56084662	0	56084662.0	3_prime_UTR_variant	0	NR	4e-09	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q22	1	155216951.0	GBAP1	GBAP1			ENSG00000160766			rs1057941-A	rs1057941	0	1057941.0	non_coding_transcript_exon_variant	0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q22	1	155212052.0	MTX1	MTX1			ENSG00000173171			rs2974935-T	rs2974935	0	2974935.0	non_coding_transcript_exon_variant	0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		1q32.2	1	210816167.0	KCNH1	KCNH1			ENSG00000143473			rs11119608-T	rs11119608	0	11119608.0	intron_variant	0	NR	1e-07	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		3q26.2	3	169043635.0	Intergenic	LINC01997 - MECOM	ENSG00000241383	ENSG00000085276		5219.0	39864.0	rs75316749-G	rs75316749	0	75316749.0	intergenic_variant	1	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p22.1	6	30374976.0	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696.0	39739.0	rs115707823-A	rs115707823	1	3129817.0	intergenic_variant	1	NR	2e-06	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.33	6	31347004.0	HLA-C	LINC02571 - HLA-B	ENSG00000256166	ENSG00000206450		45362.0	6868.0	rs115392158-G	rs115392158	1	2507997.0	intron_variant	1	NR	9e-06	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6p21.32	6	32699696.0	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313.0	6428.0	rs147527678-C	rs147527678	1	1794514.0	intergenic_variant	1	NR	5e-07	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		6q14.1	6	80398959.0	Intergenic	RPL17P25 - RPSAP72	ENSG00000219547	ENSG00000219361		24390.0	71112.0	rs4604234-C	rs4604234	0	4604234.0	intergenic_variant	1	NR	6e-06	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		9p21.3	9	21951903.0	Intergenic	MTAP - CDKN2A-DT	ENSG00000099810	ENSG00000224854		14252.0	15026.0	rs12349081-A	rs12349081	0	12349081.0	intron_variant	1	NR	6e-06	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		9p21.3	9	22062135.0	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970.0	intron_variant	0	NR	2e-07	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		12q24.12	12	111446804.0	SH2B3	ATXN2, SH2B3			ENSG00000204842, ENSG00000111252			rs3184504-C	rs3184504	0	3184504.0	missense_variant	0	NR	2e-06	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32398489.0	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833.0	stop_gained	0	NR	8e-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		17q12	17	37741642.0	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991.0	intron_variant	0	NR	1e-09	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		19p13.11	19	17279482.0	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075.0	intron_variant	0	NR	4e-07	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34131991.0	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701.0	62578.0	rs11907546-C	rs11907546	0	11907546.0	intergenic_variant	1	NR	3e-09	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		13q13.1	13	32265853.0	FRY	FRY			ENSG00000073910			rs56404467-A	rs56404467	0	56404467.0	intron_variant	0	NR	1e-07	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls		20q11.22	20	34002002.0	RALY	RALY			ENSG00000125970			rs2300206-G	rs2300206	0	2300206.0	intron_variant	0	NR	2e-08	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines		18q21.1	18	48561565.0	CTIF	CTIF, CTIF			ENSG00000282825, ENSG00000134030			rs8091660-?	rs8091660	0	8091660.0	intron_variant	0	NR	9e-06	5.045757490560675				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines		4q21.21	4	78088155.0	FRAS1	FRAS1			ENSG00000138759			rs150303591-?	rs150303591	0	150303591.0	intron_variant	0	NR	6e-07	6.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines		1q44	1	247193430.0	ZNF731P	ZNF731P			ENSG00000227671			rs12025262-?	rs12025262	0	12025262.0	intron_variant	0	NR	7e-07	6.154901959985743				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines		13q21.2	13	61317943.0	PCDH20	NA - PCDH20		ENSG00000280165			91742.0	rs10674174-?	rs10674174	0	10674174.0	intergenic_variant	1	NR	8e-07	6.096910013008056				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines		2p23.2	2	28097166.0	BRE	BABAM2			ENSG00000158019			rs7572644-?	rs7572644	0	7572644.0	intron_variant	0	NR	6e-06	5.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines		6q12	6	65027022.0	EYS	EYS			ENSG00000188107			rs201083182-?	rs201083182	0	201083182.0	intron_variant	0	NR	2e-06	5.698970004336019				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines		5q23.2	5	122442912.0	MGC32805, SNCAIP	SNCAIP, MGC32805			ENSG00000064692, ENSG00000250328			rs3842595-?	rs3842595	0	3842595.0	intron_variant	0	NR	3e-07	6.522878745280337				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines		4p15.33	4	13607505.0	BOD1L1	BOD1L1			ENSG00000038219			rs185229225-?	rs185229225	0	185229225.0	intron_variant	0	NR	2e-07	6.698970004336019				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines		3q24	3	143384827.0	SLC9A9	SLC9A9			ENSG00000181804			rs201023017-?	rs201023017	0	201023017.0	intron_variant	0	NR	6e-07	6.221848749616356				Illumina [6243550] (imputed)	N
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines		10q26.11	10	119607441.0	TIAL1	TIAL1 - RAD1P1	ENSG00000151923	ENSG00000234569		10412.0	13627.0	rs66696671-?	rs66696671	0	66696671.0	intergenic_variant	1	NR	7e-07	6.154901959985743				Illumina [6243550] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls		2q14.1	2	113215368.0	PAX8	PAX8-AS1			ENSG00000189223			rs752590-?	rs752590	0	752590.0	intron_variant	0	0.21	3e-08	7.522878745280337		1.34	[1.21-1.49]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls		2q31.1	2	176172583.0	HOXD3	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-?	rs711830	0	711830.0	3_prime_UTR_variant	0	0.32	8e-12	11.096910013008056		1.3	[1.20-1.40]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls		19q13.2	19	39242112.0	IFNL3, IFNL4	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819.0	1441.0	rs688187-?	rs688187	0	688187.0	intergenic_variant	1	0.68	7e-13	12.154901959985745		1.4925373	[1.33-1.67]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls		2q14.1	2	113258824.0	PAX8	PAX8, PAX8-AS1			ENSG00000125618, ENSG00000189223			rs72831838-?	rs72831838	0	72831838.0	non_coding_transcript_exon_variant	0	0.14	8e-07	6.096910013008056	(Invasive Only)	1.39	[1.22-1.58]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls		2q31.1	2	176172583.0	HOXD3	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-?	rs711830	0	711830.0	3_prime_UTR_variant	0	0.32	8e-07	6.096910013008056	(Invasive Only)	1.26	[1.15-1.39]	Illumina [15504273] (imputed)	N
2016-05-17	26075790	Kelemen LE	2015-06-15	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/26075790	Genome-wide significant risk associations for mucinous ovarian carcinoma.	Mucinous ovarian carcinoma	1,003 European ancestry invasive cases, 641 European ancestry low malignant potential cases, 21,693 European ancestry controls		19q13.2	19	39242112.0	IFNL3, IFNL4	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819.0	1441.0	rs688187-?	rs688187	0	688187.0	intergenic_variant	1	0.68	1e-08	8.0	(Invasive Only)	1.4084507	[1.25-1.59]	Illumina [15504273] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319447	6e-08	7.221848749616356		1.1783675	[1.11072142428685-1.25013339797474]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		3q28	3	190807727.0	NR	CCT6P4 - GMNC	ENSG00000232610	ENSG00000205835		91328.0	45010.0	rs9870207-A	rs9870207	0	9870207.0	regulatory_region_variant	1	0.691354	5e-08	7.301029995663981		1.1929355	[1.11921837700174-1.27150779447142]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		5p15.33	5	1279675.0	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690.0	intron_variant	0	0.259806	1e-09	9.0		1.2150546	[1.14168685260085-1.29313711208919]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		5p15.33	5	1285859.0	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526.0	intron_variant	0	0.332078	2e-20	19.69897000433602		1.3236618	[1.24799798080348-1.40391301421926]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		8q24.21	8	128529685.0	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482.0	intron_variant	0	0.867974	1e-16	16.0		1.465133	[1.33389097997879-1.60928789514469]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		10q24.33	10	103934543.0	NR	STN1 - SLK	ENSG00000107960	ENSG00000065613		16359.0	32597.0	rs7902587-T	rs7902587	0	7902587.0	intergenic_variant	1	0.0975691	4e-08	7.397940008672037		1.2930167	[1.18179536270929-1.41470527615789]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		17q12	17	37733029.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776.0	intron_variant	0	0.41189	1e-06	6.0		1.1517414	[1.0876255656695-1.21963673962283]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		17q21.32	17	48423311.0	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826.0	intron_variant	0	0.267801	1e-07	7.0		1.1787505	[1.10925120766678-1.25260426998392]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		18q11.2	18	23825589.0	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244.0	intron_variant	0	0.275360999999999	4e-08	7.397940008672037		1.1902364	[1.11903760649588-1.2659653630658]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		8q21.13	8	76408119.0	NR	LINC01111			ENSG00000254300			rs150293538-T	rs150293538	0	150293538.0	intron_variant	0	0.9784417	2e-09	8.698970004336019		2.1880746	[1.65336168482279-2.89571888582476]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755.0	intron_variant	0	0.486465	6e-06	5.221848749616356		1.1389422	[1.07652961941979-1.20497334696891]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous and serous borderline ovarian cancer	2,966 European ancestry cases, 40,941 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319015999999999	3e-06	5.522878745280337		1.1855859	[1.10400745880938-1.27319220749772]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA2 mutation carriers	954 European ancestry carrier cases, 11,458 European ancestry carrier controls		3q25.31	3	156717851.0	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923.0	29492.0	rs62274041-G	rs62274041	0	62274041.0	intergenic_variant	1	0.048	3e-07	6.522878745280337		1.85	[1.46354854927152-2.33435588308994]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian cancer in BRCA2 mutation carriers	954 European ancestry carrier cases, 11,458 European ancestry carrier controls		9p22.2	9	16915876.0	NR	BNC2 - NA	ENSG00000173068			45033.0		rs10962692-G	rs10962692	0	10962692.0	intergenic_variant	1	0.799624	9e-11	10.045757490560677		1.5	[1.32777950250739-1.69772989025038]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		3q25.31	3	156717851.0	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923.0	29492.0	rs62274041-G	rs62274041	0	62274041.0	intergenic_variant	1	0.048	2e-57	56.69897000433602		1.57	[1.48-1.66]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319	3e-15	14.522878745280336		1.12	[1.09-1.15]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319	3e-15	14.522878745280336		1.12	[1.09-1.15]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		1p34.3	1	37630749.0	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170.0	intron_variant	0	0.221	1e-09	9.0		1.1	[1.07-1.13]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		18q11.2	18	23825589.0	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244.0	intron_variant	0	0.275	2e-07	6.698970004336019		1.11	[1.07-1.16]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		22q12.1	22	28538325.0	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807.0	intron_variant	0	0.899	9e-06	5.045757490560675		1.1	[1.05-1.15]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		2q13	2	111061081.0	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109.0	intron_variant	0	0.251869	2e-08	7.698970004336019		1.086051	[1.05456961053472-1.11847227897416]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		8q24.21	8	127805637.0	NR	PVT1			ENSG00000249859			rs9886651-G	rs9886651	0	9886651.0	intron_variant	0	0.461222	2e-09	8.698970004336019		1.0802044	[1.05286500127646-1.10825354962066]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		12q24.31	12	120965921.0	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249.0	splice_region_variant	0	0.417632	5e-10	9.30102999566398		1.0834533	[1.05604177574809-1.1115762691869]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		3q28	3	190807727.0	NR	CCT6P4 - GMNC	ENSG00000232610	ENSG00000205835		91328.0	45010.0	rs9870207-A	rs9870207	0	9870207.0	regulatory_region_variant	1	0.691354	3e-06	5.522878745280337		1.0994674	[1.05569458307584-1.14505523813592]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		5p15.33	5	1279675.0	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690.0	intron_variant	0	0.259806	1e-07	7.0		1.0802581	[1.04978354993499-1.11161732010102]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		17q21.31	17	45489971.0	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586.0	intron_variant	0	0.181254	2e-19	18.69897000433602		1.1611373	[1.12396655984348-1.19953742102822]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		17q21.32	17	48423311.0	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826.0	intron_variant	0	0.267801	2e-17	16.69897000433602		1.1311107	[1.09941695678777-1.16371793958399]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		19p13.11	19	17279482.0	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075.0	intron_variant	0	0.295975	2e-19	18.69897000433602		1.1357577	[1.10479964302488-1.16758323338693]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian clear cell cancer	1,366 European ancestry cases, 40,941 European ancestry controls		17q12	17	37733029.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-A	rs7405776	0	7405776.0	intron_variant	0	0.58811	2e-07	6.698970004336019		1.25	[1.15-1.35]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Ovarian clear cell cancer	1,366 European ancestry cases, 40,941 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-T	rs11651755	0	11651755.0	intron_variant	0	0.513535	7e-09	8.154901959985743		1.27	[1.16-1.37]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Endometrioid ovarian cancer	2,810 European ancestry cases, 40,941 European ancestry controls		5q12.3	5	66825262.0	NR	MAST4			ENSG00000069020			rs555025179-GACAC	rs555025179	1	56076405.0	intron_variant	0	0.531475	5e-08	7.301029995663981		1.18	[1.11364451527015-1.25657782750532]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		2q14.1	2	113215368.0	NR	PAX8-AS1			ENSG00000189223			rs752590-G	rs752590	0	752590.0	intron_variant	0	0.210808	2e-12	11.69897000433602		1.2968692	[1.20743024891207-1.39293308913389]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319015999999999	1e-14	14.0		1.2736082	[1.19835894617868-1.35358269315725]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319447	1e-13	13.0		1.2623247	[1.18761263149067-1.34173680787849]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		3q23	3	139130269.0	NR	MRPS22			ENSG00000175110			rs112071820-GCCAG	rs112071820	0	112071820.0	intron_variant	0	0.283067	2e-13	12.69897000433602		1.2854952	[1.20336051010928-1.37323590882365]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		9q31.1	9	102180944.0	NR	NA - RNU6-329P		ENSG00000238882			75660.0	rs320203-A	rs320203	0	320203.0	intergenic_variant	1	0.850197	2e-08	7.698970004336019		1.2856314	[1.17544642545976-1.4061450991104]	Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-T	rs11651755	0	11651755.0	intron_variant	0	0.513535	2e-06	5.698970004336019		1.1539987		Illumina [11595112] (imputed)	N
2017-08-03	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Mucinous ovarian carcinoma	2,566 European ancestry cases, 40,941 European ancestry controls		19q13.2	19	39242112.0	NR	IFNL3P1 - IFNL3	ENSG00000268510	ENSG00000197110		4819.0	1441.0	rs688187-A	rs688187	0	688187.0	intergenic_variant	1	0.312892	1e-22	22.0		1.4258754	[1.32592116400102-1.5333648423891]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		1p34.3	1	37630749.0	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170.0	intron_variant	0	0.220826	2e-07	6.698970004336019		1.099984	[1.06129080940929-1.14008804057615]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319015999999999	3e-14	13.522878745280336		1.1312215	[1.09591680302958-1.16766347713436]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319447	2e-14	13.69897000433602		1.1323612	[1.09696977445389-1.1688944318043]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		5p15.33	5	1285859.0	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526.0	intron_variant	0	0.332078	8e-08	7.096910013008056		1.0766991	[1.04796689850078-1.10621911687371]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		6p22.1	6	28512858.0	NR	GPX6			ENSG00000198704			rs6456822-T	rs6456822	0	6456822.0	intron_variant	0	0.690887	1e-06	6.0		1.0714362	[1.04202715140265-1.10167527662683]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls					NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	4e-10	9.397940008672036		1.1702297	[1.11383386875217-1.22948084125145]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		8q24.21	8	128529685.0	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482.0	intron_variant	0	0.867974	7e-26	25.154901959985743		1.232938	[1.18577432499114-1.28197774659809]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		9p22.2	9	16915876.0	NR	BNC2 - NA	ENSG00000173068			45033.0		rs10962692-G	rs10962692	0	10962692.0	intergenic_variant	1	0.799624	4.9999999999999997e-64	63.30102999566398		1.3368285	[1.29251250189538-1.38266389898672]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls					NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	2e-11	10.69897000433602		1.11572	[1.08085025008502-1.15171484355914]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		10p12.31	10	21589903.0	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911.0	intron_variant	0	0.309302	4e-11	10.397940008672036		1.0959264	[1.06647199521962-1.12619421828606]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		17q12	17	37733029.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776.0	intron_variant	0	0.41189	2e-10	9.69897000433602		1.09	[1.06-1.12]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Epithelial ovarian cancer	16,924 European ancestry cases,68,502 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755.0	intron_variant	0	0.48646500000000004	8e-09	8.096910013008056		1.077992	[1.05087168925156-1.10581210313382]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		3q25.31	3	156717851.0	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923.0	29492.0	rs62274041-G	rs62274041	0	62274041.0	intergenic_variant	1	0.0481682	3e-46	45.52287874528034		1.5885553	[1.49139660538722-1.69204355063709]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		5p15.33	5	1279675.0	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690.0	intron_variant	0	0.259806	2e-12	11.69897000433602		1.1303236	[1.09267833241685-1.16926591871766]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		5p15.33	5	1285859.0	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526.0	intron_variant	0	0.332078	6e-10	9.221848749616356		1.1067635	[1.07188995128973-1.14277166876843]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls					NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	2e-09	8.698970004336019		1.1915798	[1.12527496598389-1.26179155485818]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		8q24.21	8	128529685.0	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482.0	intron_variant	0	0.867974	2.0000000000000002e-24	23.69897000433602		1.2746594	[1.21607733088533-1.33606352682139]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		9p22.2	9	16915876.0	NR	BNC2 - NA	ENSG00000173068			45033.0		rs10962692-G	rs10962692	0	10962692.0	intergenic_variant	1	0.799624	3e-43	42.52287874528034		1.3252935	[1.27262437839255-1.38014255146877]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls					NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	7e-11	10.154901959985745		1.1340009	[1.0921011879635-1.17750814490349]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		10p12.31	10	21589903.0	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911.0	intron_variant	0	0.309302	7e-09	8.154901959985743		1.0992962	[1.06472642475689-1.13498849236897]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		15q26.1	15	90963407.0	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282.0	2633.0	rs8037137-C	rs8037137	0	8037137.0	intergenic_variant	1	0.133618999999999	1e-07	7.0		1.1235955	[1.08-1.18]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		17q12	17	37733029.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776.0	intron_variant	0	0.41189	2e-10	9.69897000433602		1.1048253	[1.07145224223974-1.13923779281726]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755.0	intron_variant	0	0.486465	1e-08	8.0		1.0903314	[1.05822261240111-1.12341446823123]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		17q21.31	17	45489971.0	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586.0	intron_variant	0	0.181254	3e-12	11.522878745280336		1.1472089	[1.10406141518038-1.19204274035159]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		17q21.32	17	48423311.0	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826.0	intron_variant	0	0.267801	1e-14	14.0		1.13894	[1.10200256244972-1.17711551141243]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		19p13.11	19	17279482.0	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075.0	intron_variant	0	0.295975	4.0000000000000004e-24	23.39794000867204		1.1823713	[1.14473972413471-1.22123996090847]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		22q12.1	22	28538325.0	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807.0	intron_variant	0	0.898635	5e-09	8.301029995663981		1.1651025	[1.10668774857942-1.22660041924]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		2q13	2	111061081.0	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109.0	intron_variant	0	0.251869	4e-07	6.3979400086720375		1.0926361	[1.05582163841262-1.13073417257807]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		8q24.21	8	127805637.0	NR	PVT1			ENSG00000249859			rs9886651-G	rs9886651	0	9886651.0	intron_variant	0	0.461222	8e-06	5.096910013008056		1.0710524	[1.03930535696901-1.10376916464823]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous invasive ovarian cancer	14,049 European ancestry cases,40,941 European ancestry controls		12q24.31	12	120965921.0	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249.0	splice_region_variant	0	0.417632	3e-07	6.522878745280337		1.0817573	[1.04973458497305-1.11475700006623]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		4q32.3	4	166265894.0	NR	NA - Y_RNA		ENSG00000264495			47041.0	rs13113999-T	rs13113999	0	13113999.0	intergenic_variant	1	0.515695999999999	5e-08	7.301029995663981		1.2250321	[1.13870977824743-1.31789814351814]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		5p15.33	5	1279675.0	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690.0	intron_variant	0	0.259806	4e-09	8.397940008672037		1.2546542	[1.16419555293272-1.35214154339342]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		5p15.33	5	1285859.0	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526.0	intron_variant	0	0.332078	6e-19	18.22184874961636		1.3829999	[1.28830538018993-1.48465482476452]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		8q24.21	8	128529685.0	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482.0	intron_variant	0	0.867974	2e-12	11.69897000433602		1.4812524	[1.32210226140915-1.65956066549562]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		10q24.33	10	103934543.0	NR	STN1 - SLK	ENSG00000107960	ENSG00000065613		16359.0	32597.0	rs7902587-T	rs7902587	0	7902587.0	intergenic_variant	1	0.0975691	9e-07	6.045757490560675		1.3209459	[1.18528926703463-1.47212825755187]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755.0	intron_variant	0	0.486465	5e-06	5.301029995663981		1.1726217	[1.09521694178849-1.25549703248424]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		17q21.32	17	48423311.0	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826.0	intron_variant	0	0.267801	8e-06	5.096910013008056		1.1832383	[1.09949355363646-1.27336159916358]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		18q11.2	18	23825589.0	NR	LAMA3			ENSG00000053747			rs8098244-A	rs8098244	0	8098244.0	intron_variant	0	0.275360999999999	9e-06	5.045757490560675		1.1853783	[1.10016620517041-1.27719049018494]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319015999999999	5e-08	7.301029995663981		1.1790794	[1.11145306187694-1.25082055006039]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Serous borderline ovarian cancer	1,954 European ancestry cases,40,941 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319447	3e-06	5.522878745280337		1.1861752	[1.1045500086088-1.27383238173854]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		1p34.3	1	37630749.0	NR	RSPO1			ENSG00000169218			rs58722170-C	rs58722170	0	58722170.0	intron_variant	0	0.220826	8e-08	7.096910013008056		1.1063784	[1.06640418255445-1.14785110269475]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		2q31.1	2	176172583.0	NR	HAGLR, HOXD3			ENSG00000224189, ENSG00000128652			rs711830-A	rs711830	0	711830.0	3_prime_UTR_variant	0	0.319015999999999	8e-13	12.096910013008056		1.1268522	[1.09069613461779-1.16420663147032]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		2q31.1	2	176178498.0	NR	HAGLROS, HAGLR			ENSG00000226363, ENSG00000224189			rs6755777-T	rs6755777	0	6755777.0	non_coding_transcript_exon_variant	0	0.319447	5e-13	12.30102999566398		1.1282876	[1.09203474654839-1.16574376009934]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		3q25.31	3	156717851.0	NR	METTL15P1 - LINC00886	ENSG00000174912	ENSG00000240875		2923.0	29492.0	rs62274041-G	rs62274041	0	62274041.0	intergenic_variant	1	0.0481682	4.0000000000000005e-49	48.39794000867204		1.630706	[1.52886835426178-1.73932685946596]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		5p15.33	5	1279675.0	NR	TERT			ENSG00000164362			rs10069690-T	rs10069690	0	10069690.0	intron_variant	0	0.259806	5e-12	11.30102999566398		1.1310111	[1.09226786405932-1.17112854934655]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		5p15.33	5	1285859.0	NR	TERT			ENSG00000164362			rs7705526-A	rs7705526	0	7705526.0	intron_variant	0	0.332078	2e-08	7.698970004336019		1.099452	[1.06380317084564-1.13629550714478]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls					NR							chr8:82668818-G	chr8:82668818	0			1	0.0663033	9e-10	9.045757490560677		1.2026194	[1.13408089642882-1.27530001906482]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		8q24.21	8	128529685.0	NR	LINC00824			ENSG00000254275			rs1400482-G	rs1400482	0	1400482.0	intron_variant	0	0.867974	7e-22	21.154901959985743		1.2638669	[1.20425676967645-1.32642773080558]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		9p22.2	9	16915876.0	NR	BNC2 - NA	ENSG00000173068			45033.0		rs10962692-G	rs10962692	0	10962692.0	intergenic_variant	1	0.799624	1e-47	47.0		1.358497	[1.30256836396842-1.41682722055063]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		9q31.1	9	104094512.0	NR	SMC2			ENSG00000136824			rs4742903-T	rs4742903	0	4742903.0	intron_variant	0	0.563	6e-06	5.221848749616356		1.0740868	[1.04130585570624-1.10789968145028]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls					NR							chr9:136138765-G	chr9:136138765	0			1	0.194216	5e-12	11.30102999566398		1.146201	[1.10275565491329-1.19135797504449]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		10p12.31	10	21589903.0	NR	MLLT10			ENSG00000078403			rs144962376-T	rs144962376	1	71393911.0	intron_variant	0	0.309302	2e-08	7.698970004336019		1.09834	[1.06283348839533-1.13503280772478]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		15q26.1	15	90963407.0	NR	RCCD1 - PRC1	ENSG00000166965	ENSG00000198901		282.0	2633.0	rs8037137-C	rs8037137	0	8037137.0	intergenic_variant	1	0.133618999999999	7e-08	7.154901959985743		1.1363636	[1.09-1.19]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		17q12	17	37733029.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7405776-G	rs7405776	0	7405776.0	intron_variant	0	0.41189	3e-09	8.522878745280337		1.1008928	[1.06665802122163-1.1362263861189]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		17q12	17	37739849.0	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651755-C	rs11651755	0	11651755.0	intron_variant	0	0.486465	2e-08	7.698970004336019		1.0924964	[1.05939221330271-1.12663514204283]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		17q21.32	17	48423311.0	NR	SKAP1			ENSG00000141293			rs7207826-C	rs7207826	0	7207826.0	intron_variant	0	0.267801	8e-14	13.096910013008056		1.1383171	[1.1003320875334-1.17761354130912]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		19p13.11	19	17279482.0	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs4808075-C	rs4808075	0	4808075.0	intron_variant	0	0.295975	3e-26	25.522878745280337		1.1971419	[1.15799210345029-1.23761537074498]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		2q13	2	111061081.0	NR	ACOXL, MIR4435-2HG			ENSG00000153093, ENSG00000172965			rs2165109-C	rs2165109	0	2165109.0	intron_variant	0	0.251869	4e-07	6.3979400086720375		1.0954511	[1.05748739051043-1.1347778353567]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		12q24.31	12	120965921.0	NR	HNF1A-AS1			ENSG00000241388			rs7953249-G	rs7953249	0	7953249.0	splice_region_variant	0	0.417632	8e-07	6.096910013008056		1.0811644	[1.04824881016487-1.11511353852335]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		17q21.31	17	45489971.0	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs1879586-G	rs1879586	0	1879586.0	intron_variant	0	0.181254	3e-13	12.522878745280336		1.1585579	[1.11378456264581-1.20513099189349]	Illumina [11595112] (imputed)	N
2017-08-07	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	High-grade serous ovarian cancer	13,037 European ancestry cases,40,941 European ancestry controls		22q12.1	22	28538325.0	NR	TTC28			ENSG00000100154			rs6005807-C	rs6005807	0	6005807.0	intron_variant	0	0.898635	1e-08	8.0		1.1650093	[1.10493126343643-1.22835376686122]	Illumina [11595112] (imputed)	N
2017-08-04	28346442	Phelan CM	2017-03-27	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/28346442	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.	Low-grade serous ovarian cancer	1,012 European ancestry cases, 40,941 European ancestry controls		8q21.13	8	76408119.0	NR	LINC01111			ENSG00000254300			rs150293538-T	rs150293538	0	150293538.0	intron_variant	0	0.978	1e-06	6.0		3.0	[1.79409543681435-5.01001565578963]	Illumina [11595112] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		Xp22.11	X	23276803.0	Intergenic	PDCL2P1 - PTCHD1	ENSG00000228610	ENSG00000165186		78113.0	58046.0	rs972834-?	rs972834	0	972834.0	intron_variant	1	NR	7e-06	5.154901959985743		1.03	[1.02-1.05]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		18q22.1	18	65045831.0	Intergenic							rs192503876-?	rs192503876	0	192503876.0	intergenic_variant	1	NR	8e-06	5.096910013008056		3.31	[1.96-5.61]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		18q22.1	18	65221472.0	Intergenic							rs80314337-?	rs80314337	0	80314337.0	intergenic_variant	1	NR	5e-06	5.301029995663981		2.89	[1.83-4.56]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		18q23	18	75985500.0	Intergenic							rs11873753-?	rs11873753	0	11873753.0	intergenic_variant	1	NR	1e-06	6.0		1.85	[1.44-2.38]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		22q13.1	22	39337237.0	Intergenic	RPL3 - SYNGR1	ENSG00000100316	ENSG00000100321		16848.0	12688.0	rs137657-?	rs137657	0	137657.0	intergenic_variant	1	NR	8e-06	5.096910013008056		1.72	[1.35-2.17]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q12.2	16	54553941.0	LINC02183	LINC02183			ENSG00000283304			rs79219469-?	rs79219469	0	79219469.0	intron_variant	0	NR	2e-07	6.698970004336019		1.1	[1.06-1.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		17q21.31	17	43048090.0	BRCA1	BRCA1			ENSG00000012048			rs567534295-?	rs567534295	0	567534295.0	intron_variant	0	NR	5e-08	7.301029995663981		1.19	[1.12-1.26]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		1p12	1	119307920.0	Intergenic	WARS2-AS1 - LINC01780	ENSG00000231365	ENSG00000232650		31947.0	19479.0	rs12031579-?	rs12031579	0	12031579.0	intron_variant	1	NR	2e-06	5.698970004336019		1.07	[1.04-1.10]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		2q36.3	2	226482173.0	Intergenic							rs13402729-?	rs13402729	0	13402729.0	regulatory_region_variant	1	NR	3e-06	5.522878745280337		1.07	[1.04-1.09]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		2q37.3	2	242012658.0	Intergenic	LINC01237, LINC01237			ENSG00000233806, ENSG00000280686			rs7563767-?	rs7563767	0	7563767.0	intron_variant	0	NR	2e-06	5.698970004336019		1.03	[1.02-1.05]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		4q32.3	4	164203350.0	Intergenic	MARCHF1			ENSG00000145416			rs7671115-?	rs7671115	0	7671115.0	intron_variant	0	NR	8e-06	5.096910013008056		1.0309278	[1.02-1.04]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		5p15.32	5	5174755.0	Intergenic	ADAMTS16			ENSG00000145536			rs1366161-?	rs1366161	0	1366161.0	intron_variant	0	NR	3e-06	5.522878745280337		1.0309278	[1.02-1.05]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		5q31.3	5	143894315.0	Intergenic	HMHB1 - NA	ENSG00000158497			73599.0		rs151055883-?	rs151055883	0	151055883.0	intergenic_variant	1	NR	2e-06	5.698970004336019		1.08	[1.05-1.12]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		6p21.1	6	44327218.0	Intergenic	AARS2 - SPATS1	ENSG00000124608	ENSG00000249481		13871.0	15432.0	rs77663385-?	rs77663385	0	77663385.0	intron_variant	1	NR	9e-06	5.045757490560675		1.14	[1.07-1.21]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		6q24.3	6	146677054.0	Intergenic	ADGB			ENSG00000118492			rs7740903-?	rs7740903	0	7740903.0	intron_variant	0	NR	5e-07	6.301029995663981		1.1	[1.06-1.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		7q21.13	7	89698682.0	Intergenic	NA - RNU6-274P		ENSG00000239075			55938.0	rs76926936-?	rs76926936	0	76926936.0	intergenic_variant	1	NR	9e-06	5.045757490560675		1.07	[1.04-1.11]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		9q22.33	9	98579569.0	Intergenic	GABBR2			ENSG00000136928			rs73494486-?	rs73494486	0	73494486.0	intron_variant	0	NR	7e-06	5.154901959985743		1.05	[1.03-1.07]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		10q11.22	10	48270719.0	Intergenic	FRMPD2			ENSG00000170324			rs77336990-?	rs77336990	0	77336990.0	intron_variant	0	NR	2e-06	5.698970004336019		1.12	[1.07-1.17]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		13q13.3	13	39329007.0	Intergenic	LHFPL6			ENSG00000183722			rs78375425-?	rs78375425	0	78375425.0	intron_variant	0	NR	3e-06	5.522878745280337		1.06	[1.03-1.09]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q12.2	16	54553941.0	Intergenic	LINC02183			ENSG00000283304			rs79219469-?	rs79219469	0	79219469.0	intron_variant	0	NR	2e-07	6.698970004336019		1.1	[1.06-1.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q21	16	63960276.0	Intergenic							rs9989364-?	rs9989364	0	9989364.0	intergenic_variant	1	NR	9e-06	5.045757490560675		1.04	[1.02-1.06]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q22.1	16	68366522.0	Intergenic	SMPD3			ENSG00000103056			rs141803457-?	rs141803457	0	141803457.0	intron_variant	0	NR	3e-06	5.522878745280337		1.13	[1.07-1.19]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q22.1	16	68497433.0	Intergenic	RPL35AP33 - ZFP90	ENSG00000241334	ENSG00000184939		19863.0	32657.0	rs137866923-?	rs137866923	0	137866923.0	intergenic_variant	1	NR	8e-07	6.096910013008056		1.15	[1.09-1.22]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		17q22	17	57289728.0	Intergenic	MSI2			ENSG00000153944			rs139505845-?	rs139505845	0	139505845.0	intron_variant	0	NR	6e-06	5.221848749616356		1.17	[1.09-1.25]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		18q12.1	18	33625004.0	Intergenic	ASXL3			ENSG00000141431			rs138807553-?	rs138807553	0	138807553.0	intron_variant	0	NR	2e-06	5.698970004336019		1.15	[1.08-1.22]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer (MTAG)	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		18q23	18	75988278.0	Intergenic							rs78286182-?	rs78286182	0	78286182.0	intergenic_variant	1	NR	1e-06	6.0		1.08	[1.05-1.11]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q12.2	16	54553941.0	LINC02183	LINC02183			ENSG00000283304			rs79219469-?	rs79219469	0	79219469.0	intron_variant	0	NR	3e-08	7.522878745280337		2.25	[1.12-1.26]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		17q21.31	17	43048090.0	BRCA1	BRCA1			ENSG00000012048			rs567534295-?	rs567534295	0	567534295.0	intron_variant	0	NR	3e-08	7.522878745280337		4.75	[2.73-8.24]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		1p21.2	1	101301117.0	Intergenic	PPIAP7 - LINC01307	ENSG00000173810	ENSG00000231671		29754.0	22220.0	rs143623984-?	rs143623984	0	143623984.0	regulatory_region_variant	1	NR	9e-06	5.045757490560675		3.25	[1.93-5.48]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		1p12	1	119307920.0	Intergenic	WARS2-AS1 - LINC01780	ENSG00000231365	ENSG00000232650		31947.0	19479.0	rs12031579-?	rs12031579	0	12031579.0	intron_variant	1	NR	1e-06	6.0		1.73	[1.39-2.16]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		1q24.3	1	172183062.0	Intergenic	DNM3			ENSG00000197959			rs484686-?	rs484686	0	484686.0	intron_variant	0	NR	8e-06	5.096910013008056		1.3	[1.16-1.46]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		2q32.1	2	184453308.0	Intergenic	MIR548AE1 - NA	ENSG00000266808			74264.0		rs537364753-?	rs537364753	0	537364753.0	intergenic_variant	1	NR	6e-06	5.221848749616356		3.06	[1.89-4.96]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		2q33.3	2	205631096.0	Intergenic	PARD3B - NRP2	ENSG00000116117	ENSG00000118257		10934.0	50894.0	rs75693602-?	rs75693602	0	75693602.0	intergenic_variant	1	NR	7e-06	5.154901959985743		1.89	[1.43-2.49]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		2q36.3	2	226482173.0	Intergenic							rs13402729-?	rs13402729	0	13402729.0	regulatory_region_variant	1	NR	1e-06	6.0		1.74	[1.39-2.18]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		2q37.3	2	242012658.0	Intergenic	LINC01237, LINC01237			ENSG00000233806, ENSG00000280686			rs7563767-?	rs7563767	0	7563767.0	intron_variant	0	NR	2e-06	5.698970004336019		1.34	[1.19-1.51]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		3p13	3	70110053.0	Intergenic	SAMMSON			ENSG00000240405			rs146572601-?	rs146572601	0	146572601.0	intron_variant	0	NR	5e-06	5.301029995663981		2.64	[1.74-4.02]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		3p13	3	70224942.0	Intergenic	SAMMSON, MDFIC2			ENSG00000240405, ENSG00000242120			rs191223340-?	rs191223340	0	191223340.0	intron_variant	0	NR	3e-06	5.522878745280337		2.74	[1.80-4.18]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		3q26.31	3	171410134.0	Intergenic	TNIK			ENSG00000154310			rs150007914-?	rs150007914	0	150007914.0	intron_variant	0	NR	7e-06	5.154901959985743		2.23	[1.57-3.16]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		4q32.3	4	164203350.0	Intergenic	MARCHF1			ENSG00000145416			rs7671115-?	rs7671115	0	7671115.0	intron_variant	0	NR	6e-06	5.221848749616356		1.2987013	[1.16-1.45]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		4q35.1	4	185621753.0	Intergenic	SORBS2			ENSG00000154556			rs57490377-?	rs57490377	0	57490377.0	intron_variant	0	NR	9e-06	5.045757490560675		2.3	[1.59-3.32]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		5p15.32	5	5174755.0	Intergenic	ADAMTS16			ENSG00000145536			rs1366161-?	rs1366161	0	1366161.0	intron_variant	0	NR	6e-06	5.221848749616356		1.2987013	[1.16-1.45]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		5q31.2	5	139690696.0	Intergenic	CXXC5 - RNU6-236P	ENSG00000171604	ENSG00000200756		6814.0	27289.0	rs148570926-?	rs148570926	0	148570926.0	intron_variant	1	NR	3e-06	5.522878745280337		2.9	[1.86-4.52]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		5q31.3	5	143894315.0	Intergenic	HMHB1 - NA	ENSG00000158497			73599.0		rs151055883-?	rs151055883	0	151055883.0	intergenic_variant	1	NR	6e-07	6.221848749616356		1.99	[1.52-2.60]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		6p21.1	6	44327218.0	Intergenic	AARS2 - SPATS1	ENSG00000124608	ENSG00000249481		13871.0	15432.0	rs77663385-?	rs77663385	0	77663385.0	intron_variant	1	NR	8e-06	5.096910013008056		3.17	[1.91-5.26]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		6q24.3	6	146677054.0	Intergenic	ADGB			ENSG00000118492			rs7740903-?	rs7740903	0	7740903.0	intron_variant	0	NR	4e-07	6.3979400086720375		2.19	[1.62-2.97]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		7q21.13	7	89698682.0	Intergenic	NA - RNU6-274P		ENSG00000239075			55938.0	rs76926936-?	rs76926936	0	76926936.0	intergenic_variant	1	NR	8e-06	5.096910013008056		1.84	[1.41-2.41]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		8q11.21	8	48645458.0	Intergenic	LINC02847 - EFCAB1	ENSG00000253702	ENSG00000034239		24440.0	65331.0	rs148037216-?	rs148037216	0	148037216.0	intron_variant	1	NR	2e-06	5.698970004336019		3.09	[1.95-4.91]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		9q33.3	9	126011262.0	Intergenic	PBX3 - NA	ENSG00000167081			43885.0		rs147476757-?	rs147476757	0	147476757.0	intergenic_variant	1	NR	8e-06	5.096910013008056		2.6	[1.71-3.96]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		10q11.22	10	48270719.0	Intergenic	FRMPD2			ENSG00000170324			rs77336990-?	rs77336990	0	77336990.0	intron_variant	0	NR	2e-06	5.698970004336019		2.77	[1.82-4.20]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		13q13.3	13	39329007.0	Intergenic	LHFPL6			ENSG00000183722			rs78375425-?	rs78375425	0	78375425.0	intron_variant	0	NR	3e-06	5.522878745280337		1.62	[1.33-1.99]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		13q14.3	13	52517465.0	Intergenic	LINC00345 - MRPS31P4	ENSG00000235660	ENSG00000250299		28249.0	82654.0	rs141118132-?	rs141118132	0	141118132.0	intron_variant	1	NR	8e-06	5.096910013008056		3.12	[1.89-5.14]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls					Intergenic							chr14:37233727-?	chr14:37233727	0			1	NR	9e-06	5.045757490560675		3.06	[1.87-5.02]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		14q23.3	14	64414689.0	Intergenic	MTHFD1			ENSG00000100714			rs201368489-?	rs201368489	0	201368489.0	intron_variant	0	NR	4e-06	5.3979400086720375		2.8	[1.81-4.34]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q22.1	16	68366522.0	Intergenic	SMPD3			ENSG00000103056			rs141803457-?	rs141803457	0	141803457.0	intron_variant	0	NR	1e-06	6.0		3.04	[1.94-4.77]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		16q22.1	16	68497433.0	Intergenic	RPL35AP33 - ZFP90	ENSG00000241334	ENSG00000184939		19863.0	32657.0	rs137866923-?	rs137866923	0	137866923.0	intergenic_variant	1	NR	3e-07	6.522878745280337		3.82	[2.29-6.36]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		17q11.2	17	27694464.0	Intergenic	CPDP1 - LGALS9DP	ENSG00000264240	ENSG00000266786		16377.0	51668.0	rs572011593-?	rs572011593	0	572011593.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		2.89	[1.84-4.55]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		17q22	17	57289728.0	Intergenic	MSI2			ENSG00000153944			rs139505845-?	rs139505845	0	139505845.0	intron_variant	0	NR	1e-06	6.0		4.52	[2.47-8.30]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		17q24.3	17	69216249.0	Intergenic	ABCA10			ENSG00000154263			rs146540010-?	rs146540010	0	146540010.0	missense_variant	0	NR	9e-06	5.045757490560675		2.84	[1.79-4.50]	Illumina [7645193] (imputed)	N
2020-04-16	31488892	Masuda T	2019-09-05	Eur J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/31488892	GWAS of five gynecologic diseases and cross-trait analysis in Japanese.	Ovarian cancer	647 Japanese ancestry cases, 39,556 Japanese ancestry controls		18q12.1	18	33625004.0	Intergenic	ASXL3			ENSG00000141431			rs138807553-?	rs138807553	0	138807553.0	intron_variant	0	NR	2e-06	5.698970004336019		3.57	[2.12-6.01]	Illumina [7645193] (imputed)	N
2020-04-23	31001917	Grant DJ	2019-04-18	Cancer Med	www.ncbi.nlm.nih.gov/pubmed/31001917	Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.	Epithelial ovarian cancer	755 African American cases, 1,235 African American controls		4q13.3	4	69591303.0	UGT2A1/2	UGT2A1, UGT2A2			ENSG00000173610, ENSG00000271271			rs10017134-C	rs10017134	0	10017134.0	intron_variant	0	0.73	1e-06	6.0		1.4	[1.2-1.7]	Illumina [471780]	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		9q21.32	9	81548365.0		GLIS3 - TLE1	ENSG00000107249	ENSG00000196781		77199973.0	35318.0	rs72745575-?	rs72745575	0	72745575.0	intergenic_variant	1	NR	2e-06	5.698970004336019	(lmp)	2.07		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		Xp22.11	X	23151499.0		FAM3C2P - PDCL2P1	ENSG00000174028	ENSG00000228610		74732.0	46840.0	rs73468194-?	rs73468194	0	73468194.0	intron_variant	1	NR	8e-06	5.096910013008056	(mucinous_all)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		10q23.1	10	80653667.0		LINC02655			ENSG00000231082			rs74477043-?	rs74477043	0	74477043.0	non_coding_transcript_exon_variant	0	NR	7e-06	5.154901959985743	(overall)	1.51		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p14.3	7	34585100.0		NPSR1-AS1			ENSG00000197085			rs7455465-?	rs7455465	0	7455465.0	intron_variant	0	NR	8e-06	5.096910013008056	(lmp)	3.32		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2q14.1	2	113530775.0		PGM5P4-AS1			ENSG00000231943			rs74828133-?	rs74828133	1	3877418.0	intron_variant	0	NR	6e-06	5.221848749616356	(endometrioid)	1.53		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2q37.3	2	238022053.0		UBE2F, UBE2F-SCLY			ENSG00000184182, ENSG00000258984			rs74917072-?	rs74917072	0	74917072.0	intron_variant	0	NR	5e-07	6.301029995663981	(overall)	1.25		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2p24.2	2	18193172.0		KCNS3			ENSG00000170745			rs75157307-?	rs75157307	0	75157307.0	intron_variant	0	NR	3e-06	5.522878745280337	(serous_hg)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2p22.1	2	38517625.0		LINC02613 - HNRNPLL	ENSG00000231367	ENSG00000143889		1691.0	44344.0	rs7559097-?	rs7559097	0	7559097.0	intergenic_variant	1	NR	6e-06	5.221848749616356	(mucinous_all)	1.61		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3q26.32	3	176972255.0		NA - MTND5P15		ENSG00000231888			38464.0	rs7644028-?	rs7644028	0	7644028.0	intergenic_variant	1	NR	3e-06	5.522878745280337	(clearcell)	1.57		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		10q11.21	10	41850928.0								rs76731728-?	rs76731728	0	76731728.0	regulatory_region_variant	1	NR	4e-06	5.3979400086720375	(endometrioid)	1.95		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3q13.31	3	116459821.0		LSAMP			ENSG00000185565			rs77122835-?	rs77122835	0	77122835.0	intron_variant	0	NR	9e-06	5.045757490560675	(overall)	1.29		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		13q34	13	113481059.0		DCUN1D2			ENSG00000150401			rs78649302-?	rs78649302	0	78649302.0	intron_variant	0	NR	3e-06	5.522878745280337	(lmp)	1.86		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		1p31.3	1	63315469.0		LINC00466			ENSG00000224209			rs78720768-?	rs78720768	0	78720768.0	intron_variant	0	NR	4e-06	5.3979400086720375	(lmp)	2.2		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		13q12.3	13	29266071.0		MTUS2			ENSG00000132938			rs78950910-?	rs78950910	0	78950910.0	intron_variant	0	NR	9e-06	5.045757490560675	(lmp)	4.82		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q31.2	5	138171416.0		BRD8			ENSG00000112983			rs79812184-?	rs79812184	1	34106093.0	intron_variant	0	NR	7e-06	5.154901959985743	(overall)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		9q22.2	9	89469330.0		SEMA4D			ENSG00000187764			rs79925169-?	rs79925169	0	79925169.0	intron_variant	0	NR	5e-06	5.301029995663981	(overall)	1.23		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		8p22	8	13963095.0								rs80119973-?	rs80119973	0	80119973.0	intergenic_variant	1	NR	2e-06	5.698970004336019	(endometrioid)	3.03		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		16q22.3	16	73418955.0		ZFHX3, LINC01568			ENSG00000140836, ENSG00000258779			rs8060270-?	rs8060270	0	8060270.0	intron_variant	0	NR	3e-06	5.522878745280337	(mucinous_all)	1.67		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		17p13.2	17	5064847.0		SLC52A1 - ZFP3-DT	ENSG00000132517	ENSG00000262693		12838.0	10831.0	rs8069681-?	rs8069681	0	8069681.0	intergenic_variant	1	NR	1e-06	6.0	(lmp)	1.7		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		21q22.11	21	31347809.0		TIAM1			ENSG00000156299			rs845930-?	rs845930	0	845930.0	non_coding_transcript_exon_variant	0	NR	8e-06	5.096910013008056	(overall)	1.18		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		10q26.13	10	122120548.0		TACC2			ENSG00000138162			rs870274-?	rs870274	0	870274.0	intron_variant	0	NR	7e-06	5.154901959985743	(ser_lg_lmp)	1.7		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		13q14.2	13	48747718.0		CYSLTR2 - PSME2P2	ENSG00000152207	ENSG00000225131		36492.0	23410.0	rs9316411-?	rs9316411	0	9316411.0	intergenic_variant	1	NR	2e-06	5.698970004336019	(overall)	1.37		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6q11.1	6	60484461.0								rs9382808-?	rs9382808	0	9382808.0	intron_variant	1	NR	2e-06	5.698970004336019	(clearcell)	1.82		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		1p36.33	1	1175206.0		TTLL10, TTLL10-AS1			ENSG00000162571, ENSG00000205231			rs9442387-?	rs9442387	0	9442387.0	non_coding_transcript_exon_variant	0	NR	8e-06	5.096910013008056	(ser_lg_lmp)	2.78		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p14.1	7	42053156.0		GLI3			ENSG00000106571			rs9791676-?	rs9791676	0	9791676.0	intron_variant	0	NR	8e-06	5.096910013008056	(clearcell)	1.96		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		Xp22.33	X	3776745.0		RPS27AP20 - NA	ENSG00000182888			59145.0		rs113446565-?	rs113446565	0	113446565.0	intergenic_variant	1	NR	4e-06	5.3979400086720375	(endometrioid)	1.43		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7q11.22	7	71128079.0		NA - GALNT17		ENSG00000185274			4065.0	rs113494645-?	rs113494645	1	59083618.0	intergenic_variant	1	NR	9e-06	5.045757490560675	(mucinous_all)	1.79		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4q34.3	4	176652990.0		NA - VEGFC		ENSG00000150630			30548.0	rs113732232-?	rs113732232	0	113732232.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(serous_hg)	1.63		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		17p13.2	17	4274200.0		UBE2G1			ENSG00000132388			rs11426758-?	rs11426758	0	11426758.0	intron_variant	0	NR	7e-06	5.154901959985743	(mucinous_all)	1.56		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		8p12	8	31005773.0		PURG			ENSG00000172733			rs11451120-?	rs11451120	0	11451120.0	intron_variant	0	NR	8e-06	5.096910013008056	(overall)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		13q32.1	13	96391464.0		HS6ST3			ENSG00000185352			rs1164587-?	rs1164587	0	1164587.0	intron_variant	0	NR	3e-06	5.522878745280337	(mucinous_all)	1.53		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		18q21.1	18	49657424.0		SMUG1P1 - NA	ENSG00000267444			6264.0		rs11659469-?	rs11659469	0	11659469.0	intergenic_variant	1	NR	5e-06	5.301029995663981	(mucinous_all)	1.5		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2q23.3	2	150393944.0		LINC01818 - RND3	ENSG00000230645	ENSG00000115963		37484.0	74251.0	rs11684751-?	rs11684751	0	11684751.0	intergenic_variant	1	NR	4e-06	5.3979400086720375	(ser_lg_lmp)	1.74		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4q35.1	4	185843593.0		SORBS2			ENSG00000154556			rs11724690-?	rs11724690	0	11724690.0	intron_variant	0	NR	2e-06	5.698970004336019	(clearcell)	2.9		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p15.2	7	27853217.0		JAZF1			ENSG00000153814			rs11973028-?	rs11973028	0	11973028.0	intron_variant	0	NR	1e-06	6.0	(mucinous_all)	1.51		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7q33	7	133141119.0		RNU6-92P - ST13P7	ENSG00000272393	ENSG00000237821		58187.0	28297.0	rs11980115-?	rs11980115	0	11980115.0	intergenic_variant	1	NR	2e-06	5.698970004336019	(ser_lg_lmp)	4.45		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		8q24.21	8	127619425.0		NA - CASC11		ENSG00000249375			66918.0	rs12546957-?	rs12546957	0	12546957.0	intron_variant	1	NR	3e-06	5.522878745280337	(serous_hg)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		1q41	1	221657667.0		NA - DUSP10		ENSG00000143507			43757.0	rs12568748-?	rs12568748	0	12568748.0	intergenic_variant	1	NR	9e-06	5.045757490560675	(mucinous_all)	1.9		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		17q22	17	57668632.0		MSI2			ENSG00000153944			rs12603880-?	rs12603880	0	12603880.0	intron_variant	0	NR	7e-06	5.154901959985743	(clearcell)	1.59		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2p25.1	2	7182908.0		RN7SKP112 - NA	ENSG00000223145			41364.0		rs12623068-?	rs12623068	0	12623068.0	intergenic_variant	1	NR	4e-06	5.3979400086720375	(overall)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2p21	2	44110941.0		NA - RNU6-566P		ENSG00000252599			43848.0	rs13420007-?	rs13420007	0	13420007.0	intergenic_variant	1	NR	6e-06	5.221848749616356	(endometrioid)	1.56		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		22q13.31	22	46131359.0		MIRLET7BHG - PPARA	ENSG00000197182	ENSG00000186951		17431.0	19162.0	rs135573-?	rs135573	0	135573.0	TF_binding_site_variant	1	NR	3e-06	5.522878745280337	(mucinous_all)	2.45		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		13q31.3	13	90884180.0		NA - LINC00410		ENSG00000231674			6774.0	rs140884924-?	rs140884924	1	55678794.0	intergenic_variant	1	NR	8e-06	5.096910013008056	(lmp)	1.76		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		20p12.1	20	12691366.0								rs1413017-?	rs1413017	0	1413017.0	intergenic_variant	1	NR	4e-06	5.3979400086720375	(ser_lg_lmp)	1.75		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7q36.3	7	157716799.0		PTPRN2, PTPRN2			ENSG00000282185, ENSG00000155093			rs142825068-?	rs142825068	1	112728111.0	intron_variant	0	NR	8e-06	5.096910013008056	(overall)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		17q11.2	17	28302026.0		KRT18P55			ENSG00000265480			rs144055451-?	rs144055451	0	144055451.0	intron_variant	0	NR	2e-06	5.698970004336019	(serous_hg)	1.91		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		Xp11.3	X	43022624.0		SMIM15P1 - NA	ENSG00000270280			22228.0		rs144199732-?	rs144199732	0	144199732.0	intergenic_variant	1	NR	7e-07	6.154901959985743	(lmp)	2.86		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		10p15.3	10	1186289.0		ADARB2, LINC00200			ENSG00000185736, ENSG00000229205			rs145022376-?	rs145022376	0	145022376.0	intron_variant	0	NR	1e-06	6.0	(clearcell)	4.1		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6p22.3	6	17689625.0		NUP153			ENSG00000124789			rs146343288-?	rs146343288	0	146343288.0	intron_variant	0	NR	3e-06	5.522878745280337	(serous_hg)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3q13.2	3	112609782.0		CCDC80			ENSG00000091986			rs146917711-?	rs146917711	0	146917711.0	intron_variant	0	NR	4e-06	5.3979400086720375	(mucinous_all)	2.33		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		10p12.1	10	28484549.0		LINC02652			ENSG00000237128			rs1934363-C	rs1934363	0	1934363.0	intron_variant	0	0.94	3e-10	9.522878745280336	(CCOC)	11.0	[5.3-24]	Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6p25.2	6	3580855.0								rs7748275-A	rs7748275	0	7748275.0	intergenic_variant	1	0.16	9e-09	8.045757490560675	(serous)	1.4	[1.2-1.5]	Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6p25.2	6	3580855.0								rs7748275-A	rs7748275	0	7748275.0	intergenic_variant	1	0.16	4e-08	7.397940008672037	(HGSOC)	1.4	[1.2-1.5]	Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr1:22569919-?	chr1:22569919	0			1	NR	3e-06	5.522878745280337	(lmp)	3.83		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr12:121386263-?	chr12:121386263	0			1	NR	2e-07	6.698970004336019	(lmp)	2.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr12:128445504-?	chr12:128445504	0			1	NR	3e-07	6.522878745280337	(serous_hg)	1.49		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr12:45837095-?	chr12:45837095	0			1	NR	2e-06	5.698970004336019	(serous_hg)	1.4		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr12:98579587-?	chr12:98579587	0			1	NR	9e-06	5.045757490560675	(ser_lg_lmp)	6.95		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr13:45661665-?	chr13:45661665	0			1	NR	9e-06	5.045757490560675	(endometrioid)	1.54		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr14:106452461-?	chr14:106452461	0			1	NR	2e-06	5.698970004336019	(lmp)	4.73		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr16:76182702-?	chr16:76182702	0			1	NR	1e-06	6.0	(mucinous_all)	1.84		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr2:29228648-?	chr2:29228648	0			1	NR	8e-06	5.096910013008056	(clearcell)	6.32		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr1:150718602-?	chr1:150718602	0			1	NR	7e-07	6.154901959985743	(ser_lg_lmp)	2.43		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr12:118425547-?	chr12:118425547	0			1	NR	6e-06	5.221848749616356	(ser_lg_lmp)	2.1		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chr6:168526822-?	chr6:168526822	0			1	NR	7e-06	5.154901959985743	(clearcell)	1.55		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												chrX:107586364-?	chrX:107586364	0			1	NR	3e-06	5.522878745280337	(overall)	1.29		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												kgp7416783-?	kgp7416783	0			1	NR	9e-06	5.045757490560675	(clearcell)	1.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												kgp7556451-?	kgp7556451	0			1	NR	9e-08	7.045757490560675	(serous_hg)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4q31.3	4	153242242.0		TRIM2			ENSG00000109654			rs10009522-?	rs10009522	0	10009522.0	intron_variant	0	NR	9e-06	5.045757490560675	(overall)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p21.3	7	11524758.0		THSD7A			ENSG00000005108			rs10260419-?	rs10260419	0	10260419.0	intron_variant	0	NR	1e-07	7.0	(overall)	1.33		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		15q12	15	27084081.0		GABRG3, GABRG3-AS1			ENSG00000182256, ENSG00000228740			rs10400919-?	rs10400919	0	10400919.0	intron_variant	0	NR	6e-06	5.221848749616356	(clearcell)	1.55		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		1p36.12	1	21141378.0		EIF4G3			ENSG00000075151			rs10627733-?	rs10627733	0	10627733.0	intron_variant	0	NR	2e-06	5.698970004336019	(endometrioid)	1.89		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		21q21.1	21	21308069.0		NCAM2			ENSG00000154654			rs111478044-?	rs111478044	0	111478044.0	intron_variant	0	NR	9e-07	6.045757490560675	(ser_lg_lmp)	2.0		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		16q23.2	16	79856062.0		LINC01228 - NA	ENSG00000261082			28912.0		rs11150225-?	rs11150225	0	11150225.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(overall)	1.21		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q21.1	5	102301954.0		SLCO4C1 - RN7SKP68	ENSG00000173930	ENSG00000222987		5670.0	550.0	rs111970895-?	rs111970895	0	111970895.0	intergenic_variant	1	NR	3e-07	6.522878745280337	(clearcell)	2.34		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q32	5	148321490.0		SPINK9			ENSG00000204909			rs376296328-?	rs376296328	1	200597924.0	intron_variant	0	NR	8e-06	5.096910013008056	(serous_hg)	1.48		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		18q21.33	18	63664376.0		SERPINB11			ENSG00000206072			rs3867263-?	rs3867263	0	3867263.0	intron_variant	0	NR	4e-06	5.3979400086720375	(serous_hg)	1.25		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3p14.2	3	61992237.0		PTPRG			ENSG00000144724			rs40409-?	rs40409	0	40409.0	intron_variant	0	NR	2e-06	5.698970004336019	(clearcell)	1.57		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4q32.3	4	167363437.0		NA - RN7SL776P		ENSG00000240772			37058.0	rs4362851-?	rs4362851	0	4362851.0	intergenic_variant	1	NR	2e-06	5.698970004336019	(ser_lg_lmp)	1.81		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6q26	6	163301732.0		PACRG			ENSG00000112530			rs4709698-?	rs4709698	0	4709698.0	intron_variant	0	NR	3e-06	5.522878745280337	(serous_hg)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		10q25.2	10	111552672.0		RPS6P15 - NA	ENSG00000230809			53731.0		rs4918665-?	rs4918665	0	4918665.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(serous)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		11q23.1	11	111430057.0		POU2AF1			ENSG00000110777			rs4936453-?	rs4936453	0	4936453.0	intron_variant	0	NR	8e-06	5.096910013008056	(clearcell)	1.54		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p12.1	7	51423896.0		CICP17 - NA	ENSG00000227233			39236.0		rs56236040-?	rs56236040	0	56236040.0	intergenic_variant	1	NR	4e-06	5.3979400086720375	(ser_lg_lmp)	6.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6q25.1	6	151590844.0		CCDC170			ENSG00000120262			rs57960590-?	rs57960590	0	57960590.0	intron_variant	0	NR	4e-06	5.3979400086720375	(serous)	1.61		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q14.3	5	90981864.0		ADGRV1			ENSG00000164199			rs58142303-?	rs58142303	0	58142303.0	intron_variant	0	NR	7e-06	5.154901959985743	(serous)	1.63		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		Xq25	X	128926215.0		RPL32P35 - NA	ENSG00000223995			87381.0		rs5932545-?	rs5932545	0	5932545.0	intron_variant	1	NR	3e-06	5.522878745280337	(endometrioid)	1.45		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		16q12.1	16	49765545.0		ZNF423			ENSG00000102935			rs59923016-?	rs59923016	0	59923016.0	intron_variant	0	NR	1e-06	6.0	(overall)	1.21		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		22q11.21	22	19681497.0		NA - SEPTIN5		ENSG00000184702			33006.0	rs5993791-?	rs5993791	0	5993791.0	TF_binding_site_variant	1	NR	8e-06	5.096910013008056	(clearcell)	3.94		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												rs60930737-?	rs60930737	0	60930737.0		1	NR	2e-06	5.698970004336019	(ser_lg_lmp)	2.09		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		20p12.2	20	11586401.0		NA - PGAM3P		ENSG00000237256			34650.0	rs6134303-?	rs6134303	0	6134303.0	intergenic_variant	1	NR	8e-07	6.096910013008056	(mucinous_all)	1.59		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		9q21.13	9	74295222.0								rs61658193-?	rs61658193	0	61658193.0	intergenic_variant	1	NR	9e-06	5.045757490560675	(serous)	1.3		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		14q12	14	26740487.0		LINC02588						rs61974021-?	rs61974021	0	61974021.0	intron_variant	0	NR	4e-06	5.3979400086720375	(ser_lg_lmp)	4.17		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q35.3	5	177806110.0		FAM153A - OR1X5P	ENSG00000170074	ENSG00000214351		22712.0	30324.0	rs62397673-?	rs62397673	0	62397673.0	regulatory_region_variant	1	NR	3e-06	5.522878745280337	(endometrioid)	1.97		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p22.2	7	2916633.0		CARD11			ENSG00000198286			rs6461701-?	rs6461701	0	6461701.0	intron_variant	0	NR	5e-06	5.301029995663981	(clearcell)	1.6		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		8q11.21	8	50701586.0		SNTG1			ENSG00000147481			rs67729017-?	rs67729017	0	67729017.0	intron_variant	0	NR	8e-06	5.096910013008056	(mucinous_all)	2.53		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2p16.1	2	60572849.0		BCL11A - RN7SL361P	ENSG00000119866	ENSG00000242158		18382.0	67856.0	rs70959845-?	rs70959845	0	70959845.0	intergenic_variant	1	NR	4e-06	5.3979400086720375	(overall)	1.22		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		15q22.2	15	59949310.0		NA - NMNAT1P5		ENSG00000259573			15632.0	rs7172033-?	rs7172033	0	7172033.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(lmp)	1.97		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												rs71877790-?	rs71877790	0	71877790.0		1	NR	5e-06	5.301029995663981	(endometrioid)	1.56		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		16q23.3	16	81619883.0		CMIP			ENSG00000153815			rs7206411-?	rs7206411	0	7206411.0	non_coding_transcript_exon_variant	0	NR	2e-07	6.698970004336019	(clearcell)	1.65		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6p21.32	6	32541977.0		HLA-DRB5 - RNU1-61P	ENSG00000198502	ENSG00000251916		11690.0	7963.0	rs72492309-?	rs72492309	0	72492309.0	intergenic_variant	1	NR	2e-06	5.698970004336019	(serous)	1.27		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		7p11.2	7	57784687.0								rs151224156-?	rs151224156	0	151224156.0	intergenic_variant	1	NR	3e-06	5.522878745280337	(overall)	1.43		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		20p11.21	20	22393040.0								rs169225-?	rs169225	0	169225.0	intron_variant	1	NR	7e-07	6.154901959985743	(serous_hg)	1.24		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6q16.1	6	97730186.0								rs17057973-?	rs17057973	0	17057973.0	intron_variant	1	NR	8e-06	5.096910013008056	(ser_lg_lmp)	2.77		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3p25.3	3	11007643.0		SLC6A1-AS1, SLC6A1			ENSG00000232287, ENSG00000157103			rs1728807-?	rs1728807	0	1728807.0	intron_variant	0	NR	9e-06	5.045757490560675	(serous)	1.23		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q35.2	5	175210799.0		NA - ARL2BPP6		ENSG00000248355			79932.0	rs17808848-?	rs17808848	0	17808848.0	intergenic_variant	1	NR	3e-06	5.522878745280337	(ser_lg_lmp)	2.11		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		11q23.3	11	116120763.0								rs1791890-?	rs1791890	0	1791890.0	intergenic_variant	1	NR	3e-07	6.522878745280337	(mucinous_all)	1.61		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls												rs1800351-?	rs1800351	0	1800351.0	synonymous_variant	1	NR	7e-06	5.154901959985743	(lmp)	1.62		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3p24.1	3	26787883.0		LRRC3B - NA	ENSG00000179796			70346.0		rs185335029-?	rs185335029	0	185335029.0	intergenic_variant	1	NR	8e-06	5.096910013008056	(overall)	1.18		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q32	5	147579243.0		JAKMIP2-AS1			ENSG00000280780			rs185652178-?	rs185652178	0	185652178.0	intron_variant	0	NR	8e-07	6.096910013008056	(serous_hg)	1.55		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		6q24.2	6	143007986.0		LINC01277			ENSG00000229017			rs199256-?	rs199256	0	199256.0	intron_variant	0	NR	8e-06	5.096910013008056	(mucinous_all)	1.52		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4p15.33	4	14172253.0		LINC01085 - NA	ENSG00000248698			32201.0		rs200114742-?	rs200114742	0	200114742.0	intron_variant	1	NR	8e-06	5.096910013008056	(serous_hg)	1.25		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q14.3	5	87170215.0		MIR4280HG - LINC01949	ENSG00000233828	ENSG00000288569		31818.0	35193.0	rs200529678-?	rs200529678	0	200529678.0	intergenic_variant	1	NR	5e-06	5.301029995663981	(lmp)	2.59		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4q13.1	4	64932417.0		LINC02232			ENSG00000250125			rs2119438-?	rs2119438	0	2119438.0	intron_variant	0	NR	6e-06	5.221848749616356	(ser_lg_lmp)	1.77		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		2q34	2	211451963.0		ERBB4			ENSG00000178568			rs2371271-?	rs2371271	0	2371271.0	intron_variant	0	NR	6e-06	5.221848749616356	(endometrioid)	1.46		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		14q32.11	14	89546219.0		FOXN3			ENSG00000053254			rs243172-?	rs243172	0	243172.0	intron_variant	0	NR	4e-06	5.3979400086720375	(serous)	1.22		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		21q21.2	21	24659554.0								rs2829235-?	rs2829235	0	2829235.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(overall)	1.18		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3p23	3	31878815.0		OSBPL10			ENSG00000144645			rs28568660-?	rs28568660	1	10546963.0	intron_variant	0	NR	2e-06	5.698970004336019	(serous_hg)	1.28		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		4p16.3	4	3824215.0		ADRA2C - OR7E163P	ENSG00000184160	ENSG00000251166		55689.0	65141.0	rs28734075-?	rs28734075	0	28734075.0	intergenic_variant	1	NR	7e-06	5.154901959985743	(clearcell)	3.22		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		Xp21.1	X	33452415.0								rs34097398-?	rs34097398	0	34097398.0	intergenic_variant	1	NR	4e-07	6.3979400086720375	(ser_lg_lmp)	2.1		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		16q23.1	16	77008512.0								rs34344307-?	rs34344307	0	34344307.0	intergenic_variant	1	NR	1e-06	6.0	(endometrioid)	1.51		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		Xq24	X	119837616.0		UPF3B			ENSG00000125351			rs34350340-?	rs34350340	0	34350340.0	intron_variant	0	NR	4e-06	5.3979400086720375	(clearcell)	1.87		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		19p13.3	19	3197622.0		NCLN			ENSG00000125912			rs34357515-?	rs34357515	0	34357515.0	intron_variant	0	NR	1e-06	6.0	(clearcell)	1.69		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		5q34	5	165518039.0		NA - RN7SKP60		ENSG00000252794			91402.0	rs34470775-?	rs34470775	0	34470775.0	intron_variant	1	NR	8e-06	5.096910013008056	(clearcell)	2.19		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		22q12.1	22	28343530.0		TTC28			ENSG00000100154			rs35941888-?	rs35941888	0	35941888.0	intron_variant	0	NR	5e-06	5.301029995663981	(lmp)	1.66		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		1q23.1	1	159009146.0		IFI16			ENSG00000163565			rs3754464-?	rs3754464	0	3754464.0	5_prime_UTR_variant	0	NR	2e-06	5.698970004336019	(serous)	1.29		Illumina [11595112] (imputed)	N
2019-05-07	30898391	Lawrenson K	2019-03-19	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/30898391	Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.	Epithelial ovarian cancer	3,238 East Asian ancestry cases, 4,083 East Asian ancestry controls		3q26.2	3	169266197.0		MECOM			ENSG00000085276			rs987254-?	rs987254	0	987254.0	intron_variant	0	NR	8e-06	5.096910013008056	(lmp)	1.83		Illumina [11595112] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		19q13.43	19	58202868.0	ZNF274	ZNF274			ENSG00000171606			rs12151036-G	rs12151036	0	12151036.0	intron_variant	0	0.0119	5e-06	5.301029995663981		2.2075055	[1.57-3.11]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		20q13.31	20	56648010.0	TFAP2C	TFAP2C - RNU6-1146P	ENSG00000087510	ENSG00000252091		8727.0	19420.0	rs1884920-A	rs1884920	0	1884920.0	intergenic_variant	1	0.5027	8e-06	5.096910013008056		1.4064697	[1.21-1.64]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		22q13.1	22	39341089.0	SYNGR1	RPL3 - SYNGR1	ENSG00000100316	ENSG00000100321		20700.0	8836.0	rs137672-C	rs137672	0	137672.0	intergenic_variant	1	0.0601	1e-07	7.0		1.7452006	[1.42-2.15]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		1p22.1	1	93933038.0	GCLM	MTCO1P21 - ABCA4	ENSG00000226960	ENSG00000198691		4736.0	59796.0	rs185345278-A	rs185345278	0	185345278.0	intergenic_variant	1	0.0216	5e-06	5.301029995663981		2.8735633	[1.83-4.52]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		1p12	1	119307920.0	HAO2	WARS2-AS1 - LINC01780	ENSG00000231365	ENSG00000232650		31947.0	19479.0	rs12031579-G	rs12031579	0	12031579.0	intron_variant	1	0.0547	8e-07	6.096910013008056		1.8248177	[1.44-2.31]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		1q22	1	156114696.0	LMNA	LMNA			ENSG00000160789			rs188625872-C	rs188625872	0	188625872.0	5_prime_UTR_variant	0	0.0034	2e-06	5.698970004336019		3.7593985	[2.17-6.49]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		1q24.3	1	172072640.0	DNM3	DNM3			ENSG00000197959			rs12117623-C	rs12117623	0	12117623.0	intron_variant	0	0.5306	1e-06	6.0		1.312336	[1.18-1.46]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		2p11.2	2	86459965.0	KDM3A	KDM3A			ENSG00000115548			rs17027263-C	rs17027263	0	17027263.0	intron_variant	0	0.1172	2e-06	5.698970004336019		1.4430014	[1.24-1.68]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		3q27.3	3	186920430.0	RPL29P9	RPS20P14 - ST6GAL1	ENSG00000223803	ENSG00000073849		19873.0	9895.0	rs6801612-A	rs6801612	0	6801612.0	regulatory_region_variant	1	0.683	8e-06	5.096910013008056		1.328	[1.174-1.503]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		5p15.32	5	5169477.0	ADAMTS16	ADAMTS16			ENSG00000145536			rs12658731-G	rs12658731	0	12658731.0	intron_variant	0	0.6438	9e-07	6.045757490560675		1.405	[1.227-1.608]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		5q31.2	5	139712729.0	CXXC5	CXXC5 - RNU6-236P	ENSG00000171604	ENSG00000200756		28847.0	5256.0	rs147867139-A	rs147867139	0	147867139.0	intron_variant	1	0.0175	8e-06	5.096910013008056		2.197802	[1.56-3.11]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		5q35.3	5	180485036.0	CNOT6	RNU6-525P - CNOT6	ENSG00000200555	ENSG00000113300		40424.0	9343.0	rs60982503-G	rs60982503	0	60982503.0	intergenic_variant	1	0.7345	5e-06	5.301029995663981		1.384	[1.204-1.591]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		6p24.3	6	10403963.0	TFAP2A	TFAP2A			ENSG00000137203			rs303051-A	rs303051	0	303051.0	intron_variant	0	0.3947	6e-06	5.221848749616356		1.2886598	[1.15-1.44]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		6p21.31	6	35464877.0	FANCE	FANCE			ENSG00000112039			rs56855829-C	rs56855829	0	56855829.0	intron_variant	0	0.0036	2e-06	5.698970004336019		3.8022811	[2.18-6.62]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		6q16.1	6	96284381.0	FUT9	UFL1-AS1			ENSG00000233797			rs4599655-A	rs4599655	0	4599655.0	intron_variant	0	0.1365	8e-06	5.096910013008056		1.3927578	[1.21-1.61]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		6q24.3	6	146688554.0	C6orf103	ADGB			ENSG00000118492			rs73589840-C	rs73589840	0	73589840.0	intron_variant	0	0.0329	7e-06	5.154901959985743		1.7452006	[1.37-2.22]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		7p12.3	7	47770503.0	MGC16075	PKD1L1			ENSG00000158683			rs181474944-C	rs181474944	0	181474944.0	intron_variant	0	0.0150	6e-06	5.221848749616356		2.4570024	[1.67-3.62]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		7q21.13	7	89698682.0	ZNF804B	NA - RNU6-274P		ENSG00000239075			55938.0	rs76926936-T	rs76926936	0	76926936.0	intergenic_variant	1	0.0517	9e-06	5.045757490560675		1.923077	[1.44-2.56]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		9q21.33	9	87680655.0	DAPK1	DAPK1			ENSG00000196730			rs10117922-A	rs10117922	0	10117922.0	intron_variant	0	0.325	7e-06	5.154901959985743		1.3351135	[1.18-1.51]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		9q34.3	9	135247660.0	C9orf62	C9orf62						rs10858374-T	rs10858374	0	10858374.0	intron_variant	0	0.1106	1e-06	6.0		1.4684289	[1.26-1.72]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		10q25.3	10	115937294.0	ATRNL1	ATRNL1			ENSG00000107518			rs2615880-A	rs2615880	0	2615880.0	intron_variant	0	0.1234	8e-06	5.096910013008056		1.4025246	[1.21-1.63]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		12q15	12	70028700.0	C12orf28	PRANCR			ENSG00000257815			rs789336-C	rs789336	0	789336.0	intron_variant	0	0.6082	1e-07	7.0		1.369	[1.217-1.540]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		12q15	12	70148026.0	LOC100125409	PRANCR			ENSG00000257815			rs7969255-T	rs7969255	0	7969255.0	intron_variant	0	0.5313	8e-07	6.096910013008056		1.325	[1.184-1.481]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		12q15	12	70257391.0	CNOT2	CNOT2			ENSG00000111596			rs58355101-T	rs58355101	0	58355101.0	intron_variant	0	0.5658	9e-07	6.045757490560675		1.35	[1.198-1.521]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		12q15	12	70359064.0	CNOT2	CNOT2 - KCNMB4	ENSG00000111596	ENSG00000135643		4071.0	7226.0	rs1495352-A	rs1495352	0	1495352.0	intergenic_variant	1	0.5489	3e-06	5.522878745280337		1.31	[1.169-1.468]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		16q12.2	16	54596587.0	IRX3	LINC02183 - NA	ENSG00000283304			37487.0		rs75921351-C	rs75921351	0	75921351.0	intergenic_variant	1	0.0304	8e-07	6.096910013008056		2.1691973	[1.59-2.95]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		16q12.2	16	55347327.0	RPL31P56	IRX6 - RPL31P56	ENSG00000159387	ENSG00000240760		16571.0	5394.0	rs145065165-G	rs145065165	0	145065165.0	intergenic_variant	1	0.0223	2e-07	6.698970004336019		2.8735633	[1.93-4.29]	Illumina [7521072] (imputed)	N
2019-02-28	30557369	Yodsurang V	2018-12-17	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30557369	Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.	Ovarian cancer	681 Japanese ancestry cases, 17,492 Japanese ancestry controls		17p13.2	17	5857509.0	LOC339166							rs11870446-C	rs11870446	0	11870446.0	intron_variant	1	0.1238	3e-06	5.522878745280337		1.4836795	[1.26-1.75]	Illumina [7521072] (imputed)	N
2020-11-13	32887889	Rashkin SR	2020-09-04	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/32887889	Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts.	Ovarian cancer	1,259 European ancestry cases, 410,350 European ancestry controls		1p36.32	1	3779792.0		LRRC47			ENSG00000130764			rs12061931-T	rs12061931	0	12061931.0	3_prime_UTR_variant	0	NR	6e-08	7.221848749616356		5.79	NR	Affymetrix [7846216] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023.0	NR	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180.0	138878.0	rs3814113-?	rs3814113	0	3814113.0	upstream_gene_variant	1	0.68	4.0000000000000003e-29	28.39794000867204	(All invasive)	1.21	[1.17-1.25]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	9p22.2	9	16915023.0	NR	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180.0	138878.0	rs3814113-?	rs3814113	0	3814113.0	upstream_gene_variant	1	0.68	3.9999999999999997e-32	31.39794000867204	(Serious invasive)	1.28	[1.23-1.33]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703.0	MYC	LINC00824			ENSG00000254275			rs10088218-?	rs10088218	0	10088218.0	intron_variant	0	0.87	3e-12	11.522878745280336	(All invasive)	1.18	[1.13-1.24]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q24.21	8	128531703.0	NR	LINC00824			ENSG00000254275			rs10088218-?	rs10088218	0	10088218.0	intron_variant	0	0.87	1e-17	17.0	(Serious invasive)	1.29	[1.21-1.36]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905.0	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-?	rs2072590	0	2072590.0	non_coding_transcript_exon_variant	0	0.32	5e-11	10.30102999566398	(All invasive)	1.11	[1.08-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	2q31.1	2	176177905.0	NR	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-?	rs2072590	0	2072590.0	non_coding_transcript_exon_variant	0	0.32	3e-10	9.522878745280336	(Serious invasive)	1.13	[1.09-1.18]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208.0	NR	TIPARP			ENSG00000163659			rs7651446-?	rs7651446	0	7651446.0	intron_variant	0	0.05	2.0000000000000002e-29	28.69897000433602	(All invasive)	1.44	[1.35-1.54]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	3q25.31	3	156689208.0	NR	TIPARP			ENSG00000163659			rs7651446-?	rs7651446	0	7651446.0	intron_variant	0	0.05	2.0000000000000003e-34	33.69897000433602	(Serious invasive)	1.59	[1.48-1.71]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895.0	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-?	rs8170	0	8170.0	synonymous_variant	0	0.19	2e-07	6.698970004336019	(All invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	19p13.11	19	17278895.0	NR	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-?	rs8170	0	8170.0	synonymous_variant	0	0.19	3e-14	13.522878745280336	(Serious invasive)	1.19	[1.14-1.25]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138.0	NR	SKAP1			ENSG00000141293			rs9303542-?	rs9303542	0	9303542.0	intron_variant	0	0.27	6e-09	8.221848749616356	(All invasive)	1.12	[1.08-1.16]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q21.32	17	48334138.0	NR	SKAP1			ENSG00000141293			rs9303542-?	rs9303542	0	9303542.0	intron_variant	0	0.27	3e-10	9.522878745280336	(Serious invasive)	1.14	[1.09-1.18]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409.0	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			ENSG00000164695			rs11782652-A	rs11782652	0	11782652.0	intron_variant	0	0.07	6e-09	8.221848749616356	(All invasive)	1.19	[1.12-1.26]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690.0	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			ENSG00000078403			rs1243180-T	rs1243180	0	1243180.0	intron_variant	0	0.31	2e-08	7.698970004336019	(All invasive)	1.1	[1.06-1.13]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	10p12.31	10	21626690.0	NEBL, C10orf113, C10orf114, SKIDA1, DNAJC1, MLLT10	MLLT10			ENSG00000078403			rs1243180-T	rs1243180	0	1243180.0	intron_variant	0	0.31	1e-07	7.0	(Serious invasive)	1.11	[1.07-1.15]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	17q12	17	37736525.0	HNF1B, ACACA, C17orf78, TADA2A, DUSP14, SYNRG, DDX52, TBC1D3F, TBC1D3, MRPL45, GPR179, SOCS7, ARHGAP23	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs757210-G	rs757210	0	757210.0	intron_variant	0	0.37	8e-10	9.096910013008056	(Serious invasive)	1.12	[1.08-1.17]	Illumina [2508744] (imputed)	N
2013-07-12	23535730	Pharoah PD	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535730	GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.	Ovarian cancer	3,769 European ancestry cases, 4,396 European ancestry controls	211 East Asian ancestry cases, 972 East Asian ancestry controls, 39,674 European ancestry individuals, 106 Malaysian ancestry cases, 106 Malaysian ancestry controls	8q21.13	8	81741409.0	CHMP4C, FABP5, PMP2, FABP12, IMPA1, SLC10A5, ZFAND1, SNX16, FABP4	CHMP4C			ENSG00000164695			rs11782652-A	rs11782652	0	11782652.0	intron_variant	0	0.07	7e-10	9.154901959985745	(Serious invasive)	1.24	[1.16-1.33]	Illumina [2508744] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	9p22.2	9	16915023.0	BNC2	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180.0	138878.0	rs3814113-G	rs3814113	0	3814113.0	upstream_gene_variant	1	0.32	6e-50	49.22184874961636		1.2658228	[1.22-1.32]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	8q24.21	8	128531703.0	CMYC	LINC00824			ENSG00000254275			rs10088218-A	rs10088218	0	10088218.0	intron_variant	0	0.13	1e-20	20.0		1.2987013	[1.22-1.37]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	2q31.1	2	176177905.0	HOXD1	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-A	rs2072590	0	2072590.0	non_coding_transcript_exon_variant	0	0.68	9e-14	13.045757490560677		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	3q25.31	3	156689208.0	TIPARP	TIPARP			ENSG00000163659			rs7651446-A	rs7651446	0	7651446.0	intron_variant	0	0.05	6e-51	50.22184874961636		1.59	[1.48-1.70]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	19p13.11	19	17278895.0	BABAM1	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-A	rs8170	0	8170.0	synonymous_variant	0	0.19	5e-14	13.30102999566398		1.18	[1.13-1.23]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q21.32	17	48334138.0	SKAP1	SKAP1			ENSG00000141293			rs9303542-G	rs9303542	0	9303542.0	intron_variant	0	0.27	5e-15	14.30102999566398		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	8q21.13	8	81741409.0	CHMP4C	CHMP4C			ENSG00000164695			rs11782652-G	rs11782652	0	11782652.0	intron_variant	0	0.07	3e-10	9.522878745280336			[1.16-1.32]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	10p12.31	10	21626690.0	MLLT10	MLLT10			ENSG00000078403			rs1243180-A	rs1243180	0	1243180.0	intron_variant	0	0.31	1e-09	9.0		1.1	[1.06-1.14]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q12	17	37736525.0	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs757210-A	rs757210	0	757210.0	intron_variant	0	0.63	2e-08	7.698970004336019		1.11	[1.07-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	5p15.33	5	1279675.0	TERT	TERT			ENSG00000164362			rs10069690-A	rs10069690	0	10069690.0	intron_variant	0	0.26	9e-09	8.045757490560675		1.14	[1.10-1.19]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	17q21.31	17	46710944.0	PLEKHM1	NSF, NSF			ENSG00000276262, ENSG00000073969			rs183211-A	rs183211	0	183211.0	intron_variant	0	0.24	2e-13	12.69897000433602		1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p36.12	1	22141722.0	WNT4	WNT4			ENSG00000162552			rs3820282-?	rs3820282	0	3820282.0	intron_variant	0	NR	2e-08	7.698970004336019		1.11	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p34.3	1	37616450.0	RSPO1	RSPO1			ENSG00000169218			rs12039431-?	rs12039431	0	12039431.0	intron_variant	0	NR	1e-08	8.0		1.07	[1.03-1.11]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	4q26	4	119028805.0	SYNPO2	SYNPO2			ENSG00000172403			rs17329882-?	rs17329882	0	17329882.0	intron_variant	0	NR	2e-08	7.698970004336019		1.09	[1.06-1.13]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	6p22.1	6	28518321.0	GPX6	GPX6			ENSG00000198704			rs115344852-?	rs115344852	1	6456823.0	intron_variant	0	NR	6e-06	5.221848749616356		1.0638298	[1.03-1.1]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	16q21	16	58942687.0	intergenic	NA - Metazoa_SRP		ENSG00000276525			61526.0	rs8044477-?	rs8044477	0	8044477.0	intron_variant	1	NR	1e-08	8.0		1.1		Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p36.12	1	22141722.0	WNT4	WNT4			ENSG00000162552			rs3820282-?	rs3820282	0	3820282.0	intron_variant	0	NR	8e-08	7.096910013008056	(Serous)	1.12	[1.07-1.17]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	1p34.3	1	37616450.0	RSPO1	RSPO1			ENSG00000169218			rs12039431-?	rs12039431	0	12039431.0	intron_variant	0	NR	1e-11	11.0	(Serous)	1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	4q26	4	119028805.0	SYNPO2	SYNPO2			ENSG00000172403			rs17329882-?	rs17329882	0	17329882.0	intron_variant	0	NR	2e-08	7.698970004336019	(Serous)	1.11	[1.07-1.16]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	6p22.1	6	28518321.0	GPX6	GPX6			ENSG00000198704			rs115344852-?	rs115344852	1	6456823.0	intron_variant	0	NR	3e-08	7.522878745280337	(Serous)	1.098901	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2015-12-18	25581431	Kuchenbaecker KB	2015-01-12	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25581431	Identification of six new susceptibility loci for invasive epithelial ovarian cancer.	Epithelial ovarian cancer	4,368 European ancestry cases, 9,123 European ancestry controls,	2,462 European ancestry BRCA1 mutation carrier cases, 12,790 European ancestry BRCA1 mutation carrier controls, up to 631 European ancestry BRCA2 mutation carrier cases, 7,580 European ancestry BRCA2 mutation carrier controls, 9,627 European ancestry serous cases, 1,442 European ancestry non-serous cases, 21,722 European ancestry controls	16q21	16	58942687.0	intergenic	NA - Metazoa_SRP		ENSG00000276525			61526.0	rs8044477-?	rs8044477	0	8044477.0	intron_variant	1	NR	2e-07	6.698970004336019	(Serous)	1.1	[1.06-1.15]	Illumina [up to 10962898] (imputed)	N
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17278895.0	C19orf62, MERIT40	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-T	rs8170	0	8170.0	synonymous_variant	0	NR	4e-06	5.3979400086720375	(Susceptibility)	1.12	[1.07-1.17]	Illumina [540573]	N
2010-10-07	20852633	Bolton KL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852633	Common variants at 19p13 are associated with susceptibility to ovarian cancer.	Ovarian cancer	1,768 European ancestry cases, 2,353 European ancestry controls	8,739 European ancestry cases, 10,831 European ancestry controls	19p13.11	19	17283315.0	ANKLE1	ANKLE1			ENSG00000160117			rs2363956-T	rs2363956	0	2363956.0	missense_variant	0	NR	1e-07	7.0	(Susceptibility)	1.1	[1.06-1.15]	Illumina [540573]	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036.0	NR	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs17631303-?	rs17631303	0	17631303.0	intron_variant	0	NR	1e-08	8.0				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944.0	NR	NSF, NSF			ENSG00000276262, ENSG00000073969			rs183211-?	rs183211	0	183211.0	intron_variant	0	NR	3e-08	7.522878745280337				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	9p22.2	9	16915023.0	intergenic	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180.0	138878.0	rs3814113-A	rs3814113	0	3814113.0	upstream_gene_variant	1	0.66	6e-11	10.221848749616356		1.3	[1.2-1.41]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	3q25.31	3	156679960.0	intergenic	TIPARP			ENSG00000163659			rs2665390-C	rs2665390	0	2665390.0	intron_variant	0	0.043	7e-06	5.154901959985743		1.46	[1.25-1.71]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	45439036.0	intergenic	PLEKHM1, PLEKHM1, PLEKHM1			ENSG00000276358, ENSG00000225190, ENSG00000277111			rs17631303-G	rs17631303	0	17631303.0	intron_variant	0	0.19	1e-08	8.0		1.27	[1.17-1.38]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	17q21.31	17	46710944.0	intergenic	NSF, NSF			ENSG00000276262, ENSG00000073969			rs183211-A	rs183211	0	183211.0	intron_variant	0	0.23	3e-08	7.522878745280337		1.25	[1.16-1.35]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Ovarian cancer in BRCA1 mutation carriers	683 European ancestry cases, 2,044 European ancestry controls	1,706 European ancestry cases, 10,258 European ancestry controls	4q32.3	4	164987569.0	intergenic	TRIM61 - TRIM60	ENSG00000183439	ENSG00000176979		9901.0	28889.0	rs4691139-G	rs4691139	0	4691139.0	non_coding_transcript_exon_variant	1	0.48	3e-08	7.522878745280337		1.2	[1.17-1.38]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	6q25.1	6	151627231.0	intergenic	CCDC170 - ESR1	ENSG00000120262	ENSG00000091831		6038.0	29460.0	rs2046210-C	rs2046210	0	2046210.0	regulatory_region_variant	1	0.08	5e-09	8.301029995663981		1.28	[1.18-1.39]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	12p11.22	12	28002147.0	intergenic	PTHLH - NA	ENSG00000087494			29414.0		rs10771399-A	rs10771399	0	10771399.0	intergenic_variant	1	0.86	8e-06	5.096910013008056		1.18	[1.1-1.27]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	1q32.1	1	204546897.0	MDM4	MDM4			ENSG00000198625			rs2290854-A	rs2290854	0	2290854.0	intron_variant	0	0.31	1e-07	7.0		1.13	[1.08-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	10q25.2	10	112974337.0	TCF7L2	TCF7L2			ENSG00000148737			rs11196174-G	rs11196174	0	11196174.0	intron_variant	0	0.28	8e-07	6.096910013008056		1.13	[1.07-1.18]	Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	7p21.3	7	8512984.0	NR	NXPH1			ENSG00000122584			rs765855-?	rs765855	0	765855.0	intron_variant	0	NR	4e-06	5.3979400086720375				Illumina [2568349] (imputed)	N
2013-08-02	23544013	Couch FJ	2013-03-27	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/23544013	Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.	Breast Cancer in BRCA1 mutation carriers	1,426 European ancestry cases, 1,301 European ancestry controls	6,031 European ancestry cases, 5,933 European ancestry controls	19p13.11	19	17278895.0	intergenic	USHBP1, BABAM1			ENSG00000130307, ENSG00000105393			rs8170-G	rs8170	0	8170.0	synonymous_variant	0	0.48	4e-13	12.397940008672036		1.19	[1.14-1.25]	Illumina [2568349] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	3q25.31	3	156679960.0	TIPARP	TIPARP			ENSG00000163659			rs2665390-C	rs2665390	0	2665390.0	intron_variant	0	NR	3e-07	6.522878745280337		1.19	[1.11-1.27]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	1p36.12	1	22164231.0	NR	WNT4 - MIR4418	ENSG00000162552	ENSG00000266564		20262.0	102008.0	rs7521902-?	rs7521902	0	7521902.0	regulatory_region_variant	1	NR	5e-06	5.301029995663981		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	11p14.3	11	25186158.0	NR							rs12794435-?	rs12794435	0	12794435.0	intergenic_variant	1	NR	5e-06	5.301029995663981		1.16	[1.09-1.23]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	2q31.1	2	176177905.0	HOXD1, HOXD3	HAGLR, HAGLROS			ENSG00000224189, ENSG00000226363			rs2072590-T	rs2072590	0	2072590.0	non_coding_transcript_exon_variant	0	NR	5e-14	13.30102999566398		1.16	[1.12-1.21]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	8q24.21	8	128531703.0	MYC, THEM75	LINC00824			ENSG00000254275			rs10088218-G	rs10088218	0	10088218.0	intron_variant	0	NR	3e-09	8.522878745280337		1.19	[1.12-1.25]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48334138.0	SKAP1	SKAP1			ENSG00000141293			rs9303542-G	rs9303542	0	9303542.0	intron_variant	0	NR	1e-06	6.0		1.11	[1.06-1.16]	Illumina [2056878] (imputed)	N
2010-10-12	20852632	Goode EL	2010-09-19	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20852632	A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.	Ovarian cancer	1,768 European ancestry cases, 2,354 European ancestry controls	8,709 European ancestry cases, 51,764 European ancestry controls	17q21.32	17	48279758.0	NR	SKAP1			ENSG00000141293			rs2084881-?	rs2084881	0	2084881.0	intron_variant	0	NR	2e-06	5.698970004336019		1.12	[1.07-1.18]	Illumina [2056878] (imputed)	N
2009-09-04	19648919	Song H	2009-08-02	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19648919	A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.	Ovarian cancer	1,817 European ancestry cases, 2,353 European ancestry controls	6,944 European ancestry cases, 9,477 European ancestry controls	9p22.2	9	16915023.0	BNC2, LOC648570, CNTLN	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180.0	138878.0	rs3814113-T	rs3814113	0	3814113.0	upstream_gene_variant	1	0.68	5e-19	18.30102999566398		1.22	[1.16-1.27]	Illumina [up to 2000000] (imputed)	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr1:2428447-?	chr1:2428447	0			1	NR	2e-06	5.698970004336019		63.6913	[61.98-65.4]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		1p33	1	48298840.0		SPATA6			ENSG00000132122			rs146976708-?	rs146976708	0	146976708.0	missense_variant	0	NR	4e-07	6.3979400086720375		28.2301	[26.94-29.52]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												rs144914170-?	rs144914170	0	144914170.0		1	NR	2e-06	5.698970004336019		138.28	[136.25-140.31]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		1p13.2	1	114673738.0		AMPD1			ENSG00000116748			rs115092288-?	rs115092288	0	115092288.0	missense_variant	0	NR	1e-07	7.0		8.08829	[7.31-8.86]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		1q31.2	1	192554787.0		RGS21 - RGS1	ENSG00000253148	ENSG00000090104		187502.0	20976.0	rs17676711-?	rs17676711	0	17676711.0	intron_variant	1	NR	2e-07	6.698970004336019		2.14014	[1.85-2.43]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr2:112917417-?	chr2:112917417	0			1	NR	7e-06	5.154901959985743		42.8899	[41.25-44.53]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr2:220497736-?	chr2:220497736	0			1	NR	2e-08	7.698970004336019		40.6028	[39.32-41.89]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		3p21.31	3	45158636.0		CDCP1 - RPS24P8	ENSG00000163814	ENSG00000224094		12214.0	1138.0	rs80104686-?	rs80104686	0	80104686.0	intergenic_variant	1	NR	2e-06	5.698970004336019		2.50127	[2.12-2.88]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr3:136019929-?	chr3:136019929	0			1	NR	1e-06	6.0		75.6952	[73.95-77.44]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		4p14	4	40121779.0		N4BP2			ENSG00000078177			rs80192073-?	rs80192073	0	80192073.0	missense_variant	0	NR	1e-06	6.0		72.5348	[70.79-74.28]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		6p21.33	6	31129248.0		PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs74375290-?	rs74375290	0	74375290.0	intron_variant	0	NR	6e-06	5.221848749616356		2.32386	[1.96-2.69]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		6q24.3	6	145686276.0		EPM2A			ENSG00000112425			rs137852915-?	rs137852915	0	137852915.0	missense_variant	0	NR	4e-06	5.3979400086720375		41.4303	[39.85-43.01]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		7p11.2	7	57372353.0		RNU7-157P - MIR3147	ENSG00000238431	ENSG00000266168		145287.0	32672.0	rs115128033-?	rs115128033	0	115128033.0	intergenic_variant	1	NR	9e-06	5.045757490560675		16.1143	[14.89-17.34]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		7q31.32	7	122011697.0		PTPRZ1			ENSG00000106278			rs150698072-?	rs150698072	0	150698072.0	missense_variant	0	NR	4e-08	7.397940008672037		8.76932	[7.99-9.55]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		7q36.1	7	151775905.0		PRKAG2			ENSG00000106617			rs4726091-?	rs4726091	0	4726091.0	intron_variant	0	NR	3e-06	5.522878745280337		1.34051	[1.22-1.46]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		8q24.3	8	144437000.0		TONSL			ENSG00000160949			rs182634476-?	rs182634476	0	182634476.0	intron_variant	0	NR	8e-06	5.096910013008056		10.5913	[9.56-11.63]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		9p13.3	9	34972355.0		PHF24			ENSG00000122733			rs181962423-?	rs181962423	0	181962423.0	missense_variant	0	NR	8e-06	5.096910013008056		2.69781	[2.26-3.13]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		11p15.4	11	10778732.0		CTR9			ENSG00000198730			rs141131642-?	rs141131642	0	141131642.0	missense_variant	0	NR	5e-06	5.301029995663981		4.80411	[4.13-5.48]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		11q12.1	11	57776189.0		CTNND1			ENSG00000198561			rs67812265-?	rs67812265	0	67812265.0	intron_variant	0	NR	6e-06	5.221848749616356		1.43119	[1.28-1.59]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		11q24.2	11	126209490.0		RPUSD4			ENSG00000165526			rs75453040-?	rs75453040	0	75453040.0	splice_donor_variant	0	NR	8e-07	6.096910013008056		26.7083	[25.4-28.01]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		12q24.32	12	127203336.0		LINC02405 - LINC02376	ENSG00000249345	ENSG00000256292		142771.0	70929.0	rs75214037-?	rs75214037	0	75214037.0	intron_variant	1	NR	8e-06	5.096910013008056		1.55338	[1.36-1.75]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr14:23894993-?	chr14:23894993	0			1	NR	4e-07	6.3979400086720375		25.3555	[24.1-26.61]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr16:67324783-?	chr16:67324783	0			1	NR	2e-06	5.698970004336019		79.7287	[77.91-81.54]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls		17q21.2	17	41734613.0		HAP1			ENSG00000173805			rs201166499-?	rs201166499	0	201166499.0	missense_variant	0	NR	8e-06	5.096910013008056		15.9551	[14.74-17.17]	NR [666300]	N
2021-10-19	34290314	Brandes N	2021-07-21	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/34290314	Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition.	Epithelial ovarian cancer	1,112 White British ancestry cases, 147,944 White British ancestry controls												chr20:43739036-?	chr20:43739036	0			1	NR	6e-06	5.221848749616356		38.6328	[37.05-40.22]	NR [666300]	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241788683.0		GAL3ST2			ENSG00000154252			rs62193063-T	rs62193063	0	62193063.0	intron_variant	0	0.17	9.999999999999999e-185	184.0		0.5343	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	16p13.3	16	778080.0		MSLNL			ENSG00000162006			rs114590746-T	rs114590746	0	114590746.0	intron_variant	0	0.012	5e-48	47.30102999566398		1.0386	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241762574.0		D2HGDH			ENSG00000180902			rs7569717-T	rs7569717	0	7569717.0	intron_variant	0	0.27	1e-41	41.0		0.2178	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241808893.0		GAL3ST2 - NEU4	ENSG00000154252	ENSG00000204099		4606.0	172.0	rs62193087-A	rs62193087	0	62193087.0	5_prime_UTR_variant	1	0.76	4.0000000000000006e-34	33.39794000867204		0.1842	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	2q37.3	2	241784018.0		GAL3ST2			ENSG00000154252			rs73011950-A	rs73011950	0	73011950.0	intron_variant	0	0.94	9.999999999999999e-27	26.0		0.3606	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	16p13.3	16	770888.0		MSLNL			ENSG00000162006			rs12599339-T	rs12599339	0	12599339.0	missense_variant	0	0.75	6.9999999999999995e-25	24.154901959985743		0.1681	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	19p13.2	19	9025630.0		BOLA3P2 - OR1M4P	ENSG00000267332	ENSG00000267154		5646.0	57482.0	rs11672713-C	rs11672713	0	11672713.0	intergenic_variant	1	0.72	2.0000000000000002e-24	23.69897000433602		0.163	unit decrease	Affymetrix, Illumina [20300000] (imputed)	N
2020-11-24	33067605	Folkersen L	2020-10-16	Nat Metab	www.ncbi.nlm.nih.gov/pubmed/33067605	Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.	Ovarian cancer-related tumor marker CA 125 levels	21,758 European ancestry individuals	9,173 individuals	19p13.2	19	8898485.0		MUC16			ENSG00000181143			rs12976386-A	rs12976386	0	12976386.0	intron_variant	0	0.45	1e-16	16.0		0.1298	unit increase	Affymetrix, Illumina [20300000] (imputed)	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		9q34.2	9	133279294.0		ABO - Y_RNA	ENSG00000281879	ENSG00000264495		3270.0	58434.0	rs495828-G	rs495828	0	495828.0	upstream_gene_variant	1	NR	7e-11	10.154901959985745				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		9p22.2	9	16915023.0		BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		44180.0	138878.0	rs3814113-T	rs3814113	0	3814113.0	upstream_gene_variant	1	NR	2e-43	42.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		10q26.13	10	121586676.0		FGFR2			ENSG00000066468			rs1219648-A	rs1219648	0	1219648.0	intron_variant	0	NR	4.0000000000000004e-254	253.39794000867204				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		10p12.31	10	21545607.0		MLLT10			ENSG00000078403			rs7098100-G	rs7098100	0	7098100.0	intron_variant	0	NR	4e-27	26.39794000867204				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		14q32.11	14	91283251.0		CCDC88C			ENSG00000015133			rs2277509-C	rs2277509	0	2277509.0	intron_variant	0	NR	2e-11	10.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		14q32.12	14	92636964.0		RIN3			ENSG00000100599			rs10498635-C	rs10498635	0	10498635.0	intron_variant	0	NR	9e-13	12.045757490560677				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		15q26.1	15	90969037.0		PRC1-AS1, PRC1			ENSG00000258725, ENSG00000198901			rs2290202-G	rs2290202	0	2290202.0	3_prime_UTR_variant	0	NR	4e-20	19.39794000867204				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		17q11.2	17	30909727.0		ADAP2			ENSG00000184060			rs35958868-G	rs35958868	0	35958868.0	intron_variant	0	NR	5e-13	12.30102999566398				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		17q21.31	17	45818287.0		CRHR1, CRHR1, CRHR1, MAPT-AS1, MAPT-AS1, MAPT-AS1, LINC02210-CRHR1, LINC02210-CRHR1			ENSG00000276191, ENSG00000278232, ENSG00000120088, ENSG00000264589, ENSG00000281578, ENSG00000282067, ENSG00000263715, ENSG00000282456			rs4277389-A	rs4277389	0	4277389.0	intron_variant	0	NR	1.0000000000000001e-23	23.0				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		17q22	17	55117408.0		STXBP4			ENSG00000166263			rs244353-G	rs244353	0	244353.0	intron_variant	0	NR	1e-31	31.0				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		19p13.11	19	17292224.0		ABHD8			ENSG00000127220			rs4808616-C	rs4808616	0	4808616.0	3_prime_UTR_variant	0	NR	2.0000000000000002e-23	22.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		19p13.11	19	19419461.0		GATAD2A			ENSG00000167491			rs2916074-G	rs2916074	0	2916074.0	intron_variant	0	NR	2e-11	10.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		2q31.1	2	173348166.0		RPS2P18 - CDCA7	ENSG00000231735	ENSG00000144354		49654.0	6654.0	rs1550623-G	rs1550623	0	1550623.0	intron_variant	1	NR	3e-09	8.522878745280337				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		2q33.1	2	201258272.0		CASP8			ENSG00000064012			rs3769823-A	rs3769823	0	3769823.0	missense_variant	0	NR	1e-16	16.0				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		21q11.2	21	14981210.0		NRIP1			ENSG00000180530			rs2822991-T	rs2822991	0	2822991.0	intron_variant	0	NR	6e-10	9.221848749616356				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		22q12.1	22	28643439.0		TTC28			ENSG00000100154			rs1474961-C	rs1474961	0	1474961.0	intron_variant	0	NR	2e-15	14.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		3p13	3	71486187.0		FOXP1			ENSG00000114861			rs9878602-T	rs9878602	0	9878602.0	intron_variant	0	NR	4e-08	7.397940008672037				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		4q34.1	4	174924959.0		ADAM29			ENSG00000168594			rs6826366-G	rs6826366	0	6826366.0	intron_variant	0	NR	3e-28	27.522878745280337				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		4p14	4	38785595.0		TLR10 - TLR1	ENSG00000174123	ENSG00000174125		2605.0	5082.0	rs12233670-C	rs12233670	0	12233670.0	upstream_gene_variant	1	NR	8e-12	11.096910013008056				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		5p15.33	5	1279675.0		TERT			ENSG00000164362			rs10069690-C	rs10069690	0	10069690.0	intron_variant	0	NR	5e-23	22.30102999566398				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		6p23	6	13716491.0		RANBP9 - MCUR1	ENSG00000010017	ENSG00000050393		4656.0	70066.0	rs381551-G	rs381551	0	381551.0	upstream_gene_variant	1	NR	2e-12	11.69897000433602				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		6q25.1	6	151706820.0		ESR1			ENSG00000091831			rs851980-T	rs851980	0	851980.0	intron_variant	0	NR	9e-20	19.045757490560675				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		7q35	7	144377836.0		ARHGEF5, ARHGEF5			ENSG00000050327, ENSG00000284933			rs720475-G	rs720475	0	720475.0	intron_variant	0	NR	9e-11	10.045757490560677				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		8q24.21	8	128192016.0		PVT1 - RN7SKP226	ENSG00000249859	ENSG00000201782		4915.0	28488.0	rs7017073-T	rs7017073	0	7017073.0	downstream_gene_variant	1	NR	4e-14	13.397940008672036				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		8q21.13	8	75564502.0		HNF4G			ENSG00000164749			rs2941478-A	rs2941478	0	2941478.0	3_prime_UTR_variant	0	NR	5e-08	7.301029995663981				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		9q31.1	9	104094629.0		SMC2			ENSG00000136824			rs4743687-C	rs4743687	0	4743687.0	5_prime_UTR_variant	0	NR	5e-09	8.301029995663981				NR [NR]	N
2023-06-19	36819030	Guo H	2023-02-03	Front Microbiol	www.ncbi.nlm.nih.gov/pubmed/36819030	A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers.	Breast cancer or ovarian cancer (pleiotropy)	122,977 breast cancer cases, 25,509 ovarian cancer cases, 146,915 controls		9q31.2	9	108123199.0		CHCHD4P2 - RPL36AP35	ENSG00000237360	ENSG00000231810		25348.0	698498.0	rs630965-C	rs630965	0	630965.0	intergenic_variant	1	NR	9.999999999999999e-64	63.0				NR [NR]	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		10q23.2	10	86171880.0	NR	GRID1			ENSG00000182771			rs12243396-T	rs12243396	0	12243396.0	intron_variant	0	NR	5e-06	5.301029995663981		0.7423	[0.42-1.06] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		1p31.3	1	65863804.0	NR	PDE4B			ENSG00000184588			rs147138325-T	rs147138325	0	147138325.0	intron_variant	0	NR	4e-06	5.3979400086720375		0.5471	[0.32-0.78] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals					NR							chr12:55356258-T	chr12:55356258	0			1	NR	6e-06	5.221848749616356		0.4133	[0.23-0.59] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		1q32.1	1	203527110.0	NR	OPTC - ATP2B4	ENSG00000188770	ENSG00000058668		18161.0	99677.0	rs138544011-CA	rs138544011	0	138544011.0	regulatory_region_variant	1	NR	3e-06	5.522878745280337		0.3342	[0.19-0.47] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals					NR							chr12:115323654-A	chr12:115323654	0			1	NR	7e-07	6.154901959985743		0.3793	[0.23-0.53] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		2p12	2	79121070.0	NR	REG1A			ENSG00000115386			rs2070707-T	rs2070707	0	2070707.0	intron_variant	0	NR	2e-06	5.698970004336019		0.2518	[0.15-0.36] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		22q12.1	22	27807762.0	NR	MN1 - PITPNB	ENSG00000169184	ENSG00000180957		6006.0	43907.0	rs5752640-A	rs5752640	0	5752640.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.1813	[0.11-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		2q14.3	2	124177399.0	NR	CNTNAP5			ENSG00000155052			rs115676291-A	rs115676291	0	115676291.0	intron_variant	0	NR	7e-06	5.154901959985743		0.4154	[0.23-0.6] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		2q14.3	2	124314988.0	NR	CNTNAP5			ENSG00000155052			rs66530326-CT	rs66530326	0	66530326.0	intron_variant	0	NR	7e-06	5.154901959985743		0.1934	[0.11-0.28] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		3p12.3	3	76808163.0	NR	ROBO2			ENSG00000185008			rs1082422-A	rs1082422	0	1082422.0	intron_variant	0	NR	2e-06	5.698970004336019		0.6159	[0.36-0.87] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		3q11.2	3	97419624.0	NR	EPHA6			ENSG00000080224			rs113526453-T	rs113526453	0	113526453.0	intron_variant	0	NR	5e-06	5.301029995663981		1.1278	[0.65-1.61] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		3q26.32	3	177846247.0	NR	LINC02015			ENSG00000231574			rs1369564-T	rs1369564	0	1369564.0	intron_variant	0	NR	3e-06	5.522878745280337		0.2272	[0.13-0.32] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		4q26	4	113992589.0	NR	ARSJ - NA	ENSG00000180801			12862.0		rs142157655-CA	rs142157655	0	142157655.0	intergenic_variant	1	NR	9e-06	5.045757490560675		1.5034	[0.84-2.17] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		5q13.1	5	67424966.0	NR							rs146507619-A	rs146507619	0	146507619.0	intron_variant	1	NR	8e-06	5.096910013008056		0.2101	[0.12-0.3] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		5q13.3	5	76450735.0	NR	IQGAP2			ENSG00000145703			rs35893266-T	rs35893266	0	35893266.0	intron_variant	0	NR	2e-06	5.698970004336019		0.2425	[0.14-0.34] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		6p24.2	6	10841524.0	NR	TMEM14B			ENSG00000137210			rs74760478-A	rs74760478	0	74760478.0	intron_variant	0	NR	5e-06	5.301029995663981		0.2165	[0.12-0.31] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		7p14.1	7	37228787.0	NR	ELMO1			ENSG00000155849			rs139827288-T	rs139827288	0	139827288.0	intron_variant	0	NR	9e-06	5.045757490560675		0.3111	[0.17-0.45] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		9q21.33	9	84923681.0	NR	NTRK2			ENSG00000148053			rs2017441-A	rs2017441	0	2017441.0	intron_variant	0	NR	8e-06	5.096910013008056		0.1133	[0.064-0.163] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals					NR							chr10:21621903-CA	chr10:21621903	0			1	NR	1e-06	6.0		0.4261	[0.25-0.6] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals					NR							chr12:9449247-T	chr12:9449247	0			1	NR	8e-06	5.096910013008056		0.1374	[0.077-0.198] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals					NR							chr12:68091702-T	chr12:68091702	0			1	NR	9e-07	6.045757490560675		0.222	[0.13-0.31] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		8q24.13	8	121577705.0	NR	NA - HAS2		ENSG00000170961			34411.0	rs72718849-A	rs72718849	0	72718849.0	intergenic_variant	1	NR	6e-06	5.221848749616356		0.4402	[0.25-0.63] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		14q23.1	14	58210731.0	NR	ARMH4, ACTR10			ENSG00000139971, ENSG00000131966			rs58244431-A	rs58244431	0	58244431.0	intron_variant	0	NR	3e-06	5.522878745280337		0.2576	[0.15-0.37] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		9q21.33	9	87620879.0	NR	DAPK1			ENSG00000196730			rs11141915-A	rs11141915	0	11141915.0	intron_variant	0	NR	7e-06	5.154901959985743		0.2	[0.11-0.29] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		10p15.1	10	6072330.0	NR	RPL32P23 - RBM17	ENSG00000214015	ENSG00000134453		412.0	16704.0	rs10752194-A	rs10752194	0	10752194.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.184	[0.11-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		10p15.1	10	6239119.0	NR	PFKFB3			ENSG00000170525			rs11257492-A	rs11257492	0	11257492.0	intron_variant	0	NR	6e-06	5.221848749616356		0.683	[0.39-0.98] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		1p35.3	1	29843122.0	NR							rs55950243-G	rs55950243	0	55950243.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.2197	[0.13-0.31] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		10q26.3	10	133024074.0	NR	LINC01168 - ADGRA1-AS1	ENSG00000240707	ENSG00000256925		47720.0	58999.0	rs35709804-A	rs35709804	0	35709804.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.1894	[0.11-0.27] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		1p31.1	1	81655410.0	NR	ADGRL2			ENSG00000117114			rs58116956-A	rs58116956	0	58116956.0	intron_variant	0	NR	2e-06	5.698970004336019		0.4545	[0.27-0.64] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals					NR							chr12:101373070-A	chr12:101373070	0			1	NR	2e-06	5.698970004336019		0.1823	[0.11-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		1q32.1	1	204379514.0	NR	PLEKHA6 - PPP1R15B	ENSG00000143850	ENSG00000158615		1849.0	23867.0	rs35568631-A	rs35568631	1	5780234.0	intron_variant	1	NR	6e-06	5.221848749616356		0.2069	[0.12-0.3] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals					NR							chr12:132041198-T	chr12:132041198	0			1	NR	1e-08	8.0		0.2148	[0.14-0.29] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		2p12	2	80340409.0	NR	CTNNA2			ENSG00000066032			rs17018999-C	rs17018999	0	17018999.0	intron_variant	0	NR	3e-07	6.522878745280337		0.6282	[0.39-0.87] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		22q13.31	22	47124913.0	NR	TBC1D22A			ENSG00000054611			rs735252-T	rs735252	0	735252.0	intron_variant	0	NR	5e-06	5.301029995663981		0.1816	[0.1-0.26] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		Xp21.2	X	31133020.0	NR	DMD			ENSG00000198947			rs17338346-T	rs17338346	0	17338346.0	non_coding_transcript_exon_variant	0	NR	1e-05	5.0		1.8884	[1.05-2.72] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		2p24.3	2	15170390.0	NR	NBAS			ENSG00000151779			rs67654717-T	rs67654717	0	67654717.0	intron_variant	0	NR	9e-06	5.045757490560675		0.1649	[0.092-0.238] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals					NR							chr3:8504273-T	chr3:8504273	0			1	NR	4e-06	5.3979400086720375		0.163	[0.094-0.232] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		4p14	4	36092509.0	NR	ARAP2			ENSG00000047365			rs11096798-T	rs11096798	0	11096798.0	intron_variant	0	NR	9e-06	5.045757490560675		0.5053	[0.28-0.73] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		4p15.31	4	18116414.0	NR	LCORL - NA	ENSG00000178177			94538.0		rs2125653-A	rs2125653	0	2125653.0	intergenic_variant	1	NR	8e-07	6.096910013008056		0.1445	[0.087-0.202] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		5q11.2	5	59531580.0	NR	PDE4D			ENSG00000113448			rs59152766-T	rs59152766	0	59152766.0	intron_variant	0	NR	6e-06	5.221848749616356		2.4042	[1.36-3.44] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		5q15	5	97715297.0	NR	LINC01340 - NA	ENSG00000250331			25117.0		rs1816300-A	rs1816300	0	1816300.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.5632	[0.33-0.8] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		6p22.3	6	21962773.0	NR	CASC15			ENSG00000272168			rs115721567-T	rs115721567	0	115721567.0	intron_variant	0	NR	9e-06	5.045757490560675		0.4018	[0.22-0.58] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		7q31.1	7	114572597.0	NR	FOXP2			ENSG00000128573			rs144087161-T	rs144087161	0	144087161.0	intron_variant	0	NR	1e-06	6.0		0.6189	[0.37-0.87] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		7q36.3	7	155319558.0	NR	INSIG1 - BLACE	ENSG00000186480	ENSG00000204960		9323.0	37427.0	rs139156430-C	rs139156430	0	139156430.0	intergenic_variant	1	NR	8e-06	5.096910013008056		0.402	[0.23-0.58] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		8p21.3	8	19794927.0	NR	CSGALNACT1 - INTS10	ENSG00000147408	ENSG00000104613		36898.0	22464.0	rs6985728-A	rs6985728	0	6985728.0	intergenic_variant	1	NR	1e-06	6.0		0.2111	[0.13-0.3] unit decrease	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		8q22.3	8	101283767.0	NR	LINC02844 - RNU7-67P	ENSG00000253679	ENSG00000239115		20864.0	23600.0	rs681304-A	rs681304	0	681304.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.1763	[0.1-0.25] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		14q13.3	14	36881274.0	NR	SLC25A21			ENSG00000183032			rs78007224-T	rs78007224	0	78007224.0	intron_variant	0	NR	2e-06	5.698970004336019		0.3126	[0.18-0.44] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel	2,352 European ancestry individuals		8q24.3	8	140548315.0	NR	AGO2			ENSG00000123908			rs35318074-T	rs35318074	1	34521232.0	intron_variant	0	NR	7e-06	5.154901959985743		0.1871	[0.11-0.27] unit increase	Illumina [12764477] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals					NR							chr14:102823719-A	chr14:102823719	0			1	NR	5e-06	5.301029995663981		0.2847	[0.16-0.41] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		18q12.2	18	36339642.0	NR	FHOD3			ENSG00000134775			rs2847516-T	rs2847516	0	2847516.0	intron_variant	0	NR	7e-06	5.154901959985743		0.1265	[0.071-0.182] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		20q13.13	20	47960104.0	NR	RNU7-92P - LINC01522	ENSG00000238785	ENSG00000237423		55681.0	16635.0	rs6066569-T	rs6066569	0	6066569.0	regulatory_region_variant	1	NR	9e-06	5.045757490560675		0.1173	[0.066-0.169] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals					NR							chr20:56016512-T	chr20:56016512	0			1	NR	6e-06	5.221848749616356		0.197	[0.11-0.28] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in epithelial ovarian cancer	5,596 European ancestry individuals		22q12.1	22	29117568.0	NR	KREMEN1			ENSG00000183762			rs35241450-CA	rs35241450	0	35241450.0	intron_variant	0	NR	8e-06	5.096910013008056		0.123	[0.069-0.177] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		1p36.32	1	3092123.0	NR	PRDM16			ENSG00000142611			rs2376820-C	rs2376820	0	2376820.0	intron_variant	0	NR	2e-06	5.698970004336019		0.2344	[0.14-0.33] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		1p31.3	1	65863804.0	NR	PDE4B			ENSG00000184588			rs147138325-T	rs147138325	0	147138325.0	intron_variant	0	NR	1e-05	5.0		0.596	[0.33-0.86] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals					NR							chr1:217590388-A	chr1:217590388	0			1	NR	1e-05	5.0		0.5809	[0.32-0.84] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		2p21	2	44805022.0	NR	CAMKMT - NA	ENSG00000143919			32430.0		rs138082585-CG	rs138082585	1	112420119.0	regulatory_region_variant	1	NR	4e-06	5.3979400086720375		0.3585	[0.21-0.51] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		2p21	2	47011089.0	NR	TTC7A			ENSG00000068724			rs77652838-T	rs77652838	0	77652838.0	intron_variant	0	NR	4e-06	5.3979400086720375		0.6578	[0.38-0.94] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		2p12	2	80340409.0	NR	CTNNA2			ENSG00000066032			rs17018999-C	rs17018999	0	17018999.0	intron_variant	0	NR	6e-06	5.221848749616356		0.6136	[0.35-0.88] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		2q22.1	2	136288123.0	NR	HNRNPKP2 - UBBP1	ENSG00000227347	ENSG00000230037		87620.0	41318.0	rs117774911-A	rs117774911	0	117774911.0	intergenic_variant	1	NR	2e-06	5.698970004336019		5.193	[3.06-7.33] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		3p12.3	3	76485727.0	NR	ROBO2			ENSG00000185008			rs74801337-A	rs74801337	0	74801337.0	intron_variant	0	NR	2e-06	5.698970004336019		0.4268	[0.25-0.6] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		3p11.1	3	89297772.0	NR	EPHA3			ENSG00000044524			rs143886976-T	rs143886976	0	143886976.0	intron_variant	0	NR	4e-06	5.3979400086720375		0.8991	[0.52-1.28] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		4q34.1	4	173772135.0	NR	LINC02269			ENSG00000250708			rs62337885-A	rs62337885	0	62337885.0	intron_variant	0	NR	7e-06	5.154901959985743		0.2342	[0.13-0.34] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		5q11.2	5	59531580.0	NR	PDE4D			ENSG00000113448			rs59152766-T	rs59152766	0	59152766.0	intron_variant	0	NR	9e-06	5.045757490560675		2.4084	[1.35-3.47] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		5q13.3	5	76450735.0	NR	IQGAP2			ENSG00000145703			rs35893266-T	rs35893266	0	35893266.0	intron_variant	0	NR	6e-07	6.221848749616356		0.284	[0.17-0.4] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		6q12	6	64953580.0	NR	EYS			ENSG00000188107			rs7738568-T	rs7738568	0	7738568.0	intron_variant	0	NR	2e-06	5.698970004336019		0.4707	[0.28-0.66] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		7p15.3	7	23357410.0	NR	IGF2BP3			ENSG00000136231			rs78503057-A	rs78503057	0	78503057.0	intron_variant	0	NR	1e-06	6.0		0.6555	[0.39-0.92] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		7q21.3	7	95515509.0	NR	ASB4			ENSG00000005981			rs111401235-A	rs111401235	0	111401235.0	intron_variant	0	NR	8e-06	5.096910013008056		0.4668	[0.26-0.67] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		8p21.3	8	19785969.0	NR	CSGALNACT1 - INTS10	ENSG00000147408	ENSG00000104613		27940.0	31422.0	rs7821642-A	rs7821642	0	7821642.0	regulatory_region_variant	1	NR	3e-06	5.522878745280337		0.2311	[0.13-0.33] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		9p23	9	12865681.0	NR	LURAP1L - Y_RNA	ENSG00000153714	ENSG00000264495		42621.0	19640.0	rs142620543-A	rs142620543	0	142620543.0	intergenic_variant	1	NR	8e-06	5.096910013008056		0.7137	[0.4-1.03] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		9q21.33	9	87620879.0	NR	DAPK1			ENSG00000196730			rs11141915-A	rs11141915	0	11141915.0	intron_variant	0	NR	1e-06	6.0		0.239	[0.14-0.34] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		11p13	11	35219865.0	NR	CD44			ENSG00000026508			rs11323103-A	rs11323103	0	11323103.0	intron_variant	0	NR	9e-06	5.045757490560675		0.2418	[0.13-0.35] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		9q33.3	9	126858271.0	NR	ZBTB43 - ZBTB34	ENSG00000169155	ENSG00000177125		20061.0	2394.0	rs74865532-C	rs74865532	0	74865532.0	intergenic_variant	1	NR	3e-06	5.522878745280337		2.0551	[1.2-2.91] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		10p15.1	10	6030464.0	NR	IL2RA			ENSG00000134460			rs1323657-A	rs1323657	0	1323657.0	intron_variant	0	NR	2e-06	5.698970004336019		0.2081	[0.12-0.29] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals					NR							chr10:90789461-T	chr10:90789461	0			1	NR	6e-06	5.221848749616356		0.267	[0.15-0.38] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		11p14.3	11	25650836.0	NR	RPL36AP40 - LINC02699	ENSG00000240298	ENSG00000254456		62041.0	83921.0	rs151311539-A	rs151311539	0	151311539.0	intergenic_variant	1	NR	8e-06	5.096910013008056		0.2171	[0.12-0.31] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		9q22.31	9	92905580.0	NR	SNX18P2 - ALOX15P2	ENSG00000232843	ENSG00000188101		11075.0	7576.0	rs6479436-A	rs6479436	0	6479436.0	intergenic_variant	1	NR	7e-07	6.154901959985743		0.2135	[0.13-0.3] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals					NR							chr12:115323654-A	chr12:115323654	0			1	NR	3e-06	5.522878745280337		0.4053	[0.24-0.57] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals					NR							chr12:117638331-A	chr12:117638331	0			1	NR	5e-06	5.301029995663981		2.3175	[1.32-3.32] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals					NR							chr12:132058489-T	chr12:132058489	0			1	NR	4e-06	5.3979400086720375		0.1932	[0.11-0.28] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		13q12.12	13	24364286.0	NR	LINC00566 - CYCSP33	ENSG00000261498	ENSG00000233545		27165.0	36417.0	rs376435808-A	rs376435808	0	376435808.0	regulatory_region_variant	1	NR	1e-06	6.0		0.6085	[0.36-0.86] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		13q13.3	13	35896592.0	NR	DCLK1			ENSG00000133083			rs11450161-G	rs11450161	0	11450161.0	intron_variant	0	NR	6e-06	5.221848749616356		0.4323	[0.25-0.62] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		14q22.3	14	57015823.0	NR	OTX2-AS1			ENSG00000248550			rs4898923-C	rs4898923	0	4898923.0	intron_variant	0	NR	3e-06	5.522878745280337		0.2575	[0.15-0.37] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		15q26.3	15	100153308.0	NR	ADAMTS17			ENSG00000140470			rs28538685-T	rs28538685	0	28538685.0	intron_variant	0	NR	7e-06	5.154901959985743		3.5474	[2-5.09] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		16p13.2	16	9015221.0	NR	USP7 - C16orf72	ENSG00000187555	ENSG00000182831		39893.0	76423.0	rs35925564-A	rs35925564	0	35925564.0	intergenic_variant	1	NR	7e-06	5.154901959985743		0.3693	[0.21-0.53] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		18q22.1	18	65675931.0	NR	NA - CDH7		ENSG00000081138			74321.0	rs148873983-A	rs148873983	0	148873983.0	intergenic_variant	1	NR	2e-06	5.698970004336019		0.5391	[0.32-0.76] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		21q22.2	21	38573750.0	NR	ERG			ENSG00000157554			rs140397425-A	rs140397425	0	140397425.0	intron_variant	0	NR	5e-06	5.301029995663981		1.1596	[0.66-1.66] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		22q12.1	22	25815823.0	NR	MYO18B			ENSG00000133454			rs116481116-T	rs116481116	0	116481116.0	intron_variant	0	NR	3e-06	5.522878745280337		1.2571	[0.73-1.78] unit increase	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	1,751 European ancestry individuals		22q12.1	22	27807762.0	NR	MN1 - PITPNB	ENSG00000169184	ENSG00000180957		6006.0	43907.0	rs5752640-A	rs5752640	0	5752640.0	intergenic_variant	1	NR	4e-06	5.3979400086720375		0.2011	[0.12-0.29] unit decrease	Illumina [12759548] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		1q22	1	156545504.0	NR	IQGAP3			ENSG00000183856			rs111440978-CTT	rs111440978	1	34641885.0	intron_variant	0	NR	8e-06	5.096910013008056		0.1311	[0.074-0.189] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		2p22.2	2	36756075.0	NR	VIT			ENSG00000205221			rs183171911-A	rs183171911	0	183171911.0	intron_variant	0	NR	8e-06	5.096910013008056		0.8475	[0.47-1.22] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		2p12	2	80339512.0	NR	CTNNA2			ENSG00000066032			rs56928399-A	rs56928399	0	56928399.0	intron_variant	0	NR	2e-06	5.698970004336019		0.4797	[0.28-0.68] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		3p14.3	3	55592887.0	NR	ERC2			ENSG00000187672			rs1875108-T	rs1875108	0	1875108.0	intron_variant	0	NR	5e-06	5.301029995663981		0.1342	[0.076-0.192] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		3q26.32	3	177846247.0	NR	LINC02015			ENSG00000231574			rs1369564-T	rs1369564	0	1369564.0	intron_variant	0	NR	8e-06	5.096910013008056		0.2428	[0.14-0.35] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		3q29	3	197379538.0	NR	DLG1-AS1 - NA	ENSG00000227375			75783.0		rs9841147-A	rs9841147	0	9841147.0	regulatory_region_variant	1	NR	3e-06	5.522878745280337		0.1559	[0.09-0.222] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		4p16.2	4	4870660.0	NR	MSX1 - LDHAP1	ENSG00000163132	ENSG00000251587		6724.0	23522.0	rs116521001-A	rs116521001	0	116521001.0	regulatory_region_variant	1	NR	2e-06	5.698970004336019		0.366	[0.22-0.52] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		5q15	5	97715297.0	NR	LINC01340 - NA	ENSG00000250331			25117.0		rs1816300-A	rs1816300	0	1816300.0	intergenic_variant	1	NR	1e-06	6.0		0.6306	[0.38-0.89] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		6p12.3	6	48070152.0	NR	PTCHD4			ENSG00000244694			rs10595258-G	rs10595258	0	10595258.0	intron_variant	0	NR	2e-06	5.698970004336019		0.1817	[0.11-0.26] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		7p12.3	7	48200991.0	NR	ABCA13			ENSG00000179869			rs35878068-G	rs35878068	0	35878068.0	intron_variant	0	NR	9e-06	5.045757490560675		0.134	[0.075-0.193] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		7q31.1	7	108471296.0	NR	PNPLA8			ENSG00000135241			rs13238345-T	rs13238345	0	13238345.0	3_prime_UTR_variant	0	NR	6e-06	5.221848749616356		0.3228	[0.18-0.46] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		8q11.23	8	53908184.0	NR	RGS20			ENSG00000147509			rs111774916-C	rs111774916	0	111774916.0	intron_variant	0	NR	6e-06	5.221848749616356		0.4504	[0.26-0.65] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		9p24.2	9	4460023.0	NR	RNU6-694P - SLC1A1	ENSG00000200941	ENSG00000106688		73467.0	30445.0	rs74855156-T	rs74855156	0	74855156.0	intergenic_variant	1	NR	9e-06	5.045757490560675		0.1932	[0.11-0.28] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr10:21536523-A	chr10:21536523	0			1	NR	7e-06	5.154901959985743		0.403	[0.23-0.58] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr10:77083827-T	chr10:77083827	0			1	NR	6e-06	5.221848749616356		0.3469	[0.2-0.5] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr12:106057893-T	chr12:106057893	0			1	NR	6e-06	5.221848749616356		0.3981	[0.23-0.57] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr14:96677435-T	chr14:96677435	0			1	NR	6e-06	5.221848749616356		0.132	[0.075-0.189] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		15q15.1	15	41722121.0	NR	MGA			ENSG00000174197			rs202172222-CA	rs202172222	0	202172222.0	intron_variant	0	NR	3e-06	5.522878745280337		0.2031	[0.12-0.29] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr16:10600523-CT	chr16:10600523	0			1	NR	2e-06	5.698970004336019		0.1958	[0.11-0.28] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr16:15927591-A	chr16:15927591	0			1	NR	3e-06	5.522878745280337		0.136	[0.079-0.193] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals					NR							chr17:52101271-A	chr17:52101271	0			1	NR	8e-06	5.096910013008056		0.322	[0.18-0.46] unit decrease	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		20p11.21	20	24332133.0	NR	RNU1-23P - NA	ENSG00000200231			94735.0		rs80077319-A	rs80077319	0	80077319.0	intergenic_variant	1	NR	4e-07	6.3979400086720375		0.3647	[0.22-0.51] unit increase	Illumina [12770451] (imputed)	N
2021-10-08	34162658	Quinn MC	2021-06-23	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/34162658	Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer.	Progression free survival in serous epithelial ovarian cancer	4,037 European ancestry individuals		22q12.1	22	29117568.0	NR	KREMEN1			ENSG00000183762			rs35241450-CA	rs35241450	0	35241450.0	intron_variant	0	NR	7e-06	5.154901959985743		0.1377	[0.078-0.198] unit decrease	Illumina [12770451] (imputed)	N
2022-11-04	34930913	Dai H	2021-12-21	Cell Discov	www.ncbi.nlm.nih.gov/pubmed/34930913	Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women.	Overall survival in ovarian cancer	1,346 Chinese ancestry individuals	784 Chinese ancestry individuals	3p26.1	3	4709568.0		ITPR1			ENSG00000150995			rs7631664-G	rs7631664	0	7631664.0	intron_variant	0	0.1521	9e-10	9.045757490560677		1.58	[1.37-1.83]	Illumina [6577217] (imputed)	N
2022-11-04	34930913	Dai H	2021-12-21	Cell Discov	www.ncbi.nlm.nih.gov/pubmed/34930913	Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women.	Overall survival in ovarian cancer	1,346 Chinese ancestry individuals	784 Chinese ancestry individuals	8p23.1	8	8164189.0		ENPP7P1			ENSG00000249188			rs142897723-GA	rs142897723	1	57874171.0	intron_variant	0	0.5964	4e-06	5.3979400086720375		0.66	[0.55-0.78]	Illumina [6577217] (imputed)	N
2023-04-03	34648354	Pietzner M	2021-11-12	Science	www.ncbi.nlm.nih.gov/pubmed/34648354	Mapping the proteo-genomic convergence of human diseases.	Ovarian cancer G-protein coupled receptor 1 levels	10,708 European ancestry individuals		1q24.2	1	169537838.0		F5			ENSG00000198734			rs10800453-A	rs10800453	0	10800453.0	intron_variant	0	0.27	2e-13	12.69897000433602		0.109	[0.08-0.138] unit decrease	Affymetrix, Illumina [10200000] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2p25.3	2	630070.0		LINC01875 - TMEM18	ENSG00000225942	ENSG00000151353		83403.0	33807.0	rs66906321-T	rs66906321	0	66906321.0	intergenic_variant	1	NR	1e-08	8.0	(random effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2q24.2	2	160772472.0		RBMS1 - RN7SL423P	ENSG00000153250	ENSG00000244372		278665.0	105075.0	rs146071273-A	rs146071273	0	146071273.0	intergenic_variant	1	NR	8e-09	8.096910013008056	(fixed effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2q32.1	2	187377642.0		CALCRL			ENSG00000064989			rs62172372-A	rs62172372	0	62172372.0	intron_variant	0	NR	1e-08	8.0	(fixed effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		2q37.1	2	232651825.0		EFHD1			ENSG00000115468			rs34755199-A	rs34755199	0	34755199.0	intron_variant	0	NR	9e-09	8.045757490560675	(2-sided ASSET)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		6p24.3	6	7231610.0		RREB1			ENSG00000124782			rs9379084-A	rs9379084	0	9379084.0	missense_variant	0	NR	9e-09	8.045757490560675	(random effect)			NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		15q15.3	15	43896656.0		FRMD5			ENSG00000171877			rs533143-T	rs533143	0	533143.0	intron_variant	0	NR	4e-10	9.397940008672036				NR [NR] (imputed)	N
2023-07-21	36929942	Lindstrom S	2023-03-17	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/36929942	Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions.	Cancer (pleiotropy)	122,977 European ancestry breast cancer cases, 55,168 European ancestry colorectal cancer cases, 12,906 European ancestry endometrial cancer cases, 4,112 European ancestry esophageal cancer cases, 12,488 European ancestry glioma cancer cases, 6,034 European ancestry head and neck cancer cases, 29,266 European ancestry lung cancer cases, 12,814 European ancestry melanoma cancer cases, 22,406 European ancestry ovarian cancer cases, 8,638 European ancestry pancreatic cancer cases, 79,166 European ancestry prostate cancer cases, 10,784 European ancestry renal cancer cases, 532,864 European ancestry controls		18q21.31	18	57650664.0		ATP8B1			ENSG00000081923			rs8097764-A	rs8097764	0	8097764.0	intron_variant	0	NR	1e-08	8.0	(random effect)			NR [NR] (imputed)	N
2023-06-23	35870639	Surapaneni A	2022-07-21	Kidney Int	www.ncbi.nlm.nih.gov/pubmed/35870639	Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension.	Ovarian cancer G-protein coupled receptor 1 level in Chronic kidney disease with hypertension and no diabetes (12503_5)	466 African American individuals		17q11.2	17	28367840.0		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-A	rs704	0	704.0	missense_variant	0	0.56	1e-12	12.0		0.43	[0.31-0.55] unit increase	Illumina [14870897] (imputed)	N
